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ABSTRACT 
 
THE ELECTRICAL PROPERTIES OF HUMAN TISSUE FOR THE DIAGNOSIS 
AND TREATMENT OF MELANOMA SKIN CANCER 
 
By 
Glenn Cameron Stante 
 
 This thesis discusses the research, experimental methods, and data gathered for 
the investigation of a novel method for the diagnosis of melanoma skin cancer.  First, a 
background about human skin tissue is presented.  Then, a detailed description of 
melanoma along with current diagnosis techniques and treatment options are presented.  
In the experimental methods, the electrical properties of several types of tissue were 
analyzed, the purpose of which was to discover if a tissue type can be distinguished by its 
electrical properties alone.  This would allow for the diagnosis of melanoma to be done 
by examining the electrical properties of the suspected tumor and comparing the results 
to known values of healthy and cancerous skin.  After analyzing the data, it was 
concluded that tissue types can be identified by their electrical properties and it may be 
possible to diagnose melanoma through this method.  Finally, the possibility of using a 
similar technology and radiofrequency tissue ablation to treat melanoma is presented.
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Introduction 
 
Thesis Objective 
  
The objective of this thesis is to create, test, and evaluate a new method for the 
diagnosis of skin cancer.  This new diagnosis method utilizes bipolar electrodes and an 
analysis of the electrical properties of the skin to differentiate between healthy and 
cancerous tissue.  This thesis includes the initial steps in developing this new diagnostic 
method.  In order to complete the objective of examining the electrical properties of skin, 
a fixture was designed and fabricated and the electrical properties of skin analogues were 
measured.  The purpose of this data is to determine if there is a statistical difference 
between healthy and cancerous tissue.   
The objective of this thesis is also to discuss future steps that can be taken to 
extend this technology to include a method of skin cancer treatment using radio 
frequency tissue ablation.  The technology to ablate cancerous tissue is similar to the 
diagnosis technology discussed in this thesis.  To accomplish this objective, previous uses 
of tissue ablation to treat cancer were researched and are discussed.   
 
Purpose of Thesis 
 
 The purposes of this thesis are to: 1) present information on skin cancer, 2) 
identify a new method of diagnosing skin cancer, 3) collect preliminary data on such a 
method of skin cancer diagnosis, 4) review previous research in the area of radio 
frequency tissue ablation to treat cancer, and 5) make conclusions on these new methods 
of diagnosing and treating skin cancer.  This thesis also outlines the next steps that need 
to be taken to further develop this technology.  
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Background 
 
The Skin 
 
 In order to understand skin cancer, it will be helpful first to have an understanding 
of skin and the different layers of tissue that comprise it.  The skin is the largest organ in 
the human body [1].  The surface area of skin is approximately 22 square feet and weighs 
between 10 and 11 pounds, depending on body size [2].  The primary functions of skin 
are to [3]:  
• protect the body from damage and infection  
 
• excrete salts, wastes, and water to help the body maintain homeostasis 
 
• sense touch, pain, pressure, and temperature  
 
• regulate body temperature 
  
• store fat 
 
• synthesize vitamin D which allows the small intestines to absorb calcium and 
phosphorus into the bloodstream 
 
The skin consists of three main layers of tissue (see Figure 1 [4]).  From the most 
external to internal, these layers are the: epidermis, dermis, and subcutis.  The epidermis 
is approximately one hundredths of an inch thick.  The thickness of the dermis varies 
between 0.012 inches to 0.12 inches, depending on the area of the body.  The thickness of 
the subcutis varies greatly from person to person depending on the amount of body fat.  
The epidermis will be the main concern of the experiments discussed later in this thesis, 
so the structure of the epidermis will be focused on. 
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Figure 1 – Skin Cross Section 
 
A cross section showing the different layers of skin 
 
 
 
 
 
The purpose of the epidermis is to protect the deeper layers of skin [5].  The main 
type of cells in the epidermis is keratinocytes.  Nine out of ten cells in the epidermis are 
keratinocytes [3].  Keratinocytes produce a protein called keratin, which contributes to 
the skin's ability to protect the body by making the skin hydrophobic [5].  The epidermis 
is separated into 5 layers of cells.  These layers, from the most external to internal, are 
the: stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and 
stratum basale [3].  The stratum corneum is composed of dead keratinocytes that 
originated in the stratum basale and have migrated outwards.  The stratum basale is the 
deepest layer of the epidermis.  This layer contains cells that continuously divide to 
produce new keratinocytes.  When a cell in the stratum basale layer divides, one cell stays 
in the basal layer and retains the ability to divide.  The other cell loses the ability to 
Figure 1 – Skin Cross Section 
Section 
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divide and moves into a higher layer of the epidermis (see Figure 2 [6]).  The rate of 
division at the stratum basale is the same as the rate at which dead cells are shed off of 
the body in the stratum corneum.  This allows the number of cells in each layer to stay 
constant [6].  The other layers of the epidermis do not perform specific functions but are 
simply a progression of skin cells from internal to outer layers.   
 
The stratum basale layer also contains melanocytes.  Melanocytes produce a 
protein called melanin [7].  The purpose of melanin is to protect the cells of the epidermis 
from ultraviolet light [3].  The importance of protecting skin cells from UV light is 
discussed in the “What Causes Melanoma” section.  Melanin is also the source of 
pigmentation of the skin [2].  When skin is exposed to ultraviolet light, the melanocytes 
produce more melanin, which causes the skin to darken [1].   
The next layer of tissue in skin is the dermis.  The dermis is thicker than the 
epidermis. The purpose of the dermis is to contain hair follicles, sweat glands, nerves, 
and blood vessels.  The dermis is held together by a layer of collagen [5].   
Figure 2 – Normal Skin Growth 
 
The migration of skin cells from the basal layer 
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The deepest layer of the skin is the subcutis.  The subcutis consists of a network of fat 
cells and collagen.  The purpose of the subcutis is to conserve heat and act as a shock 
absorber to prevent injury to the deeper structures of the body [5].   
Now that a basic understanding of the anatomy of skin has been established, a 
discussion about cancer and skin cancer specifically, may take place. 
 
Cancer 
 
 This section will discuss a generalized definition of cancer, the cause of cancer, 
and the types of cancer.  A specific discussion about skin cancer will take place in the 
next section, “Skin Cancer.”   
Cancer is a term used to describe a disease in which abnormal cells divide and 
multiply without control and are able to invade other parts of the body [8].  Instead of 
dying after a normal life cycle, cancer cells outlive normal cells and continue to form 
other abnormal cells.  Cancer develops due to damage to the DNA of the cell that controls 
normal growth and division [5].  A change to a cell's DNA is called a mutation.  
Mutations occur for a variety of reasons that will be discussed later.  The extra cells that 
form due to the mutation form a mass called a tumor.  A tumor can be either benign or 
malignant.  Benign tumors are not cancerous, meaning the cells do not spread to other 
parts of the body.  Tumors that are malignant are cancerous and can invade other parts of 
the body.  When cancer cells from a tumor invade other areas of the body, it is called 
metastasis [6].  If the spread of cancer cells are not controlled, death can result from the 
cancer cells interfering with the normal functions of the tissues of the body [9].   
There are five types of cancer: carcinoma, sarcoma, leukemia, lymphoma, and 
central nervous system cancers.  Carcinomas begin in the skin or in the epithelial cells 
6 
 
that cover internal organs.  Sarcomas begin in the bone, cartilage, fat, muscle, blood 
vessels, or other connective or supportive tissue.  Leukemia begins in the bone marrow.  
Lymphoma cancers begin in the cells that make up the immune system.  Central nervous 
system cancers begin the brain or spinal cord [4].   
Tumors are structurally different from normal tissue.  Because the cells that 
compose tumors are caused by an over proliferation of cells, the cell density of tumors is 
higher than normal tissue [10].  This causes tumors to have different electrical properties 
than normal tissue, which is discussed further in the “Electrical Properties of Skin” 
section and will become important when trying to diagnose cancerous tissues using 
electrical properties.  
 
Skin Cancer 
 
Now that the structure and functions of skin have been discussed and a basic 
understanding of cancer has been established, the different cancers that are associated 
with the skin can be discussed.  The three most common types of skin cancer are: basal 
cell carcinoma, squamous cell carcinoma, and melanoma.  Because melanoma is the 
deadliest type of skin cancer, it will be discussed in depth.  For the remainder of this 
thesis, when the term “skin cancer” is mentioned, it is assumed that this term is referring 
to melanoma, unless otherwise specified.  The following sections will discuss the 
physiology, causes, risk factors, and prognosis of melanoma skin cancer. 
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 Melanoma 
 
Introduction to Melanoma 
 
 Melanoma is a carcinoma of the skin and is the most deadly type of skin cancer.  
Melanoma is more likely than other types of skin cancer to become malignant and spread 
to other areas of the body [9], often to the lungs and liver [11].  Each year, approximately 
53,600 people are diagnosed with melanoma.  In Western countries, the number of people 
diagnosed with melanoma is increasing each year.  In the United States for example, the 
percentage to people diagnosed with melanoma has doubled in the last 30 years [12]. 
 
What is Melanoma? 
  
Melanoma is a type of cancer that originates in the melanocytes of the epidermis 
[12].  Melanoma often begins as non-cancerous benign tumors [7].  These non-cancerous 
tumors are called, “nevi,” or their common name, “moles.”  Nevi are clusters of 
melanocytes and surrounding connective tissue [12].  Most nevi are harmless but some 
can develop into cancerous melanoma through mutations in the DNA of the melanocytes 
[7].  Once the melanocytes become malignant, melanoma has developed.   
Melanoma is characterized by unchecked growth and replication of melanocytes 
(see  Figure 3 [6]) [12].  Melanoma tumors are often brown or black in color because the 
extra melanocytes continue to produce melanin, darkening the area around the melanoma 
[7].  The most common area for melanoma to develop is on the skin.  This type of 
melanoma is called cutaneous melanoma.  Melanoma can also develop in other tissues 
where melanocytes are present, such as in the eye, the meninges, the digestive tract, or 
the lymph nodes [12].  These less common types of melanoma will not be discussed 
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further in this thesis.  When the tern “melanoma” is used, it is referring to cutaneous 
melanoma. 
  
As melanoma progresses from a cancerous nevus to later stages, it invades the 
deeper layers of tissue below the epidermis (see the “Staging Melanoma” section).  
However, it does not do so in a uniform manner.   Melanoma invades the dermis and 
subcutis and dermis with finger-like projections (see figure 4 [12]).   This non-uniformity 
will become important later on when discussing the possibility of the diagnosis of 
melanoma via electrical properties, which is the main purpose of this thesis. 
 
Figure 3 - Beginning of Cancerous Growth 
 
The progression of Melanoma 
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What Causes Melanoma? 
 
 Melanoma is caused by DNA mutation in the melanocytes.  These mutations are 
usually caused by exposure to ultraviolet light, which create an error in the DNA 
sequence but may also be caused by inherited genetic mutations or exposure to dangerous 
chemicals.   
When genes that control the normal growth and replication of melanocytes are 
damaged, melanoma can result.  Some of the specific gene mutations that result in 
melanoma have been identified.  One non-inherited gene mutation that is found in 
melanoma is to the BRAF gene.  The BRAF gene is responsible for making a protein 
called BRA-F, which is involved in cell replication.  When the gene becomes damaged, 
the cell may no longer replicate correctly.  A mutation to the BRAF gene has been found 
in 70% of all melanoma cancers [7].   
One type of inherited gene mutation (meaning it is not caused by exposure to 
ultraviolet light) that may cause melanoma is the CDKN2A (also known as p16) gene and 
the CDK4 gene.  These genes are responsible for controlling the growth of melanocytes.  
Figure 4 - Cancer Histology 
 
4 slides showing the progression of melanoma 
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Mutations to these genes cause cell overgrowth which can lead to cancer [7].  Since these 
gene mutations can be inherited, they may be the reason why people with a family history 
of melanoma are more likely to develop melanoma themselves. 
 
Where on the Body does Melanoma Occur? 
 
 Melanoma can occur anywhere on the skin.  However, there are areas that are 
more likely than others to develop melanoma [12].  Males are more likely to develop 
melanoma on the trunk (the area between the shoulders and the hips).  Women are most 
likely to develop melanoma on the legs.  The neck and face are other common areas for 
the development of melanoma [7]. 
 
Who is at Risk for Developing Melanoma? 
 
 There are certain risk factors that can increase a person’s chance of developing 
melanoma.  People that have been exposed to more risk factors are at a higher risk for 
developing melanoma than others.  A risk factor is anything that raises a person’s chance 
of developing a disease, such as cancer.  Some risk factors are characteristics that can be 
inherited; others are due to the environment the person has been exposed to during his or 
her lifetime.  Examples of risk factors include: exposure to ultraviolet light, a large 
number of moles on the skin, fair skin, and a family history of melanoma. 
High exposure to ultraviolet light is the most significant risk factor for the 
development of melanoma.  Exposure to ultraviolet light can damage the DNA in 
melanocytes, which can cause mutations that lead to cancer [7].  High ultraviolet 
exposure also increases the production of melanin by the melanocytes.  If the 
melanocytes become fatigued, it is possible that they will be more likely to develop into 
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melanoma [7].  Areas of previous severe sunburns are also more likely to develop 
melanoma due to ultraviolet damage.   
 Another risk factor in the development of melanoma is a large number of nevisent 
on the body.  Most people have nevi, and usually these nevi will not become cancerous.  
But anyone with over 50 nevi on their body is at a higher risk of at least one nevus 
becoming cancerous [12].  Another risk factor associated with nevi is the presence of 
dysplastic nevi, which are abnormal nevi.  It has been shown that nevi that are abnormal 
in size and shape, or have the appearance of melanoma, are more likely to develop into 
melanoma.  A dysplastic nevus has a 6% to 10% chance of becoming cancerous during 
the lifetime of the person.  The development of dysplastic nevi and their correlation with 
melanoma is hereditary.  A person with a family history of melanoma is 50% more likely 
to develop melanoma themselves [7].   
A family history of melanoma is a risk factor for the development of the disease.  
Ten percent of people who have been diagnosed with melanoma already have had a close 
family member (parent, sibling, or child) diagnosed with the disease.  The increased risk 
for people with family members already diagnosed with melanoma may be due to 
inherited traits or similar lifestyles [12]. 
Fair skin, light eyes, and light colored hair are other risk factors in the 
development of melanoma [9].  People with light skin have less melanin in their skin to 
protect the DNA in their skin from ultraviolet light.  The protective effects of high 
amounts of melanin can be best seen when comparing the diagnosis rates of melanoma 
between Caucasians, who have low amount of melanin, with African Americans, who 
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have comparatively high amounts of melanin.  Caucasians are more than 10 times more 
likely to develop melanoma than African Americans [7]. 
 
Diagnosing Melanoma 
 
 For all cancers, the early diagnosis of the disease can greatly improve the 
prognosis.  It is important to correctly diagnose cancer early in order to start treatment 
and stop the disease from spreading to other tissues.  If the cancer is allowed to spread to 
other areas of the body, it becomes harder to treat and the chance of death increases.  The 
initial diagnosis of melanoma is done visually, and then confirmed pathologically.  A 
diagnosis is made by a doctor.  If a doctor suspects melanoma after a visual inspection, 
they can perform an excisional or incisional biopsy to confirm the diagnosis. 
 The first sign of melanoma is the change in appearance of an existing nevus or the 
appearance of a new nevus.  Doctors use the ABCD method as a rule for visually 
diagnosing melanoma.  Each letter stands for a warning sign of melanoma (see Figure 5 
[4]).  They are as follows [12]: 
 A-asymmetry.  The shape of one half of the mole does not match the other. 
 
 B-border.  The edges of the mole are ragged, blurred, or irregular. 
 
 C-color.  The color of the mole is uneven, or contains multiple colors. 
 
 D-diameter.  The mole increases in diameter. 
 
 If after using this method the doctor suspect’s melanoma, they will make a biopsy 
to send to a pathologist, who will then make a more definitive diagnosis.  The pathologist 
will look at the tissue sample under a microscope to determine if it contains cancerous 
cells.   
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There are two types of biopsies used to diagnose melanoma: excisional and 
incisional biopsies.  In an excisional biopsy, the doctor will remove the entire suspected 
tumor.  A downside to an excisional biopsy is that since a large amount of tissue is 
Figure 5 – Melanoma ABCDs 
 
The 4 signs of melanoma used to make a visual diagnosis 
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removed, healing times can be long and a scar where the tissue was removed may result 
[7].  In an incisional biopsy, the doctor only removes a portion of the tumor.  There are 
two types of incisional biopsies: a shave biopsy and punch biopsy.  In a shave biopsy, the 
doctor shaves off the top layer of skin with a scalpel.  Shave biopsies are not often used 
when melanoma is suspected because the tissue sample may not be thick enough to 
determine how deep the melanoma has progressed through the skin [7].  In a punch 
biopsy, the doctor uses a tool that resembles a small cookie cutter to remove a core 
sample of the tumor.  This sample includes deeper tissue such as the dermis and upper 
subcutis. 
All melanoma diagnosis techniques currently used are invasive to the patient and 
can lead to scarring of the skin.  A diagnosis method that does not cause damage to the 
skin is desired by patients and physicians.  The purpose of the experiments performed 
later in this thesis is to develop a non-invasive diagnosis method for melanoma. 
 
Staging Melanoma 
 
 Once a positive diagnosis of melanoma has been made, the extent to which the 
disease has grown and spread through the body must be determined.  Cancer can spread 
through the body in three ways.  The first is by growing and invading the surrounding 
tissue.  Another way cancer can spread is through the lymph vessels and nodes.  In this 
method, cancer cells break off from the original tumor and enter the lymph system and 
travel to other parts of the body where they can then become established in other tissues.  
This form of spreading through the body is called metastasis (see Figure 6 [6]).  The final 
way cancer can spread through the body is entering the bloodstream and traveling to 
other areas of the body via the blood vessels, which is another form of metastasis [1].   
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The process of determining how large the tumor has grown and how far the cancer 
has spread is called staging.  To stage cancer, more tests must be performed.  The stage of 
the cancer greatly effects the treatment and prognosis, as cancers that have progressed 
further will be harder to treat. 
 To stage melanoma, additional tests are performed by a doctor.  After the initial 
biopsy to diagnose the cancer, a sentinel lymph node biopsy may be performed.  In this 
procedure, radioactive dye is injected into the skin near the site of the tumor.  The doctor 
watches the flow of the dye through a fluoroscope as it travels through the lymph system 
to the nearest lymph node (the sentinel lymph node).  The doctor will then remove this 
lymph node and send it to a pathologist to determine if cancer cells have traveled to it [1].  
Other tests include a chest x-ray, CT scan, MRI, and blood tests.  All these tests are used 
to determine if the cancer has spread from the original site to other tissues in the body.  
Once the doctor knows how far the cancer has spread, if at all, a stage can be assigned to 
the cancer. 
Figure 6 – Melanoma Metastasis 
 
The invasion and metastasis of melanoma 
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The purpose of staging cancer is to give the doctor an easy and fast way of 
communicating information to other doctors about how far a case of cancer has 
progressed in a patient.  By having standard criteria for describing the state of cancer in 
different patients, treatment options can also be standardized. 
 Staging of cancer includes three different categories: T, N, and M.  Each letter 
stands for a certain characteristic of the cancer and contains important information about 
the stage of the cancer.  The following descriptions of the T, N, and M categories are 
taken from American Cancer Society's Guide to Understanding Melanoma [7]. 
 
 The T category stands for tumor.  The T category is assigned a number (from 0 to 
4) based on the tumor's thickness (how far into the skin it has grown). It is also 
assigned the letter "a" if it is not ulcerated or a "b" if it is ulcerated. Ulceration 
means a layer of skin covering the melanoma is absent. Ulceration is determined 
under a microscope after a biopsy. 
 
 To assign a T value to a case of melanoma, a physician uses a micrometer to 
measure how deep the cancer has spread on a tissue sample from a biopsy.  
The possible values of T are as follows: 
 
■ TX: Primary tumor cannot be assessed. 
 T0: No evidence of primary tumor. 
 Tis: Melanoma in situ (the cancer has not moved from the original site). 
 T1a: The melanoma is less than or equal to 1.0 mm thick, without 
ulceration. 
 T1b: The melanoma is less than or equal to 1.0 mm thick, with ulceration. 
 T2a: The melanoma is between 1.01 and 2.0 mm thick without ulceration. 
 T2b: The melanoma is between 1.01 and 2.0 mm thick with ulceration. 
 T3a: The melanoma is between 2.01 and 4.0 mm thick without ulceration. 
 T3b: The melanoma is between 2.01 and 4.0 mm thick with ulceration. 
 T4a: The melanoma is thicker than 4.0 mm without ulceration. 
 T4b: The melanoma is thicker than 4.0 mm with ulceration. 
 
 The N category stands for spread to nearby lymph nodes (see Figure 7 [11] on 
how a sentinel lymph node biopsy is preformed).  The N category is assigned a 
number (from 0 to 3) based on whether the melanoma cells have spread to lymph 
nodes or are found in the lymphatic channels connecting the lymph nodes. The N 
category is also assigned the letter "a" if melanoma cells can only be seen under a 
microscope or the letter "b" if they can be seen with the naked eye. The letter "c" 
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is assigned if there are very small amounts of melanoma in the nearby skin or if 
the melanoma is in skin lymphatic channels around the tumor. 
 
 
 To assign an N value to a case of melanoma, the results of a sentinel lymph 
node biopsy are used.  The possible values of N are as follows: 
 
■ NX: Nearby lymph nodes cannot be assessed. 
 N0: No spread to nearby lymph nodes. 
 N1a: The melanoma has spread to 1 nearby lymph node and the 
melanoma in the lymph node is only seen under the microscope. 
 N1b: The melanoma has spread to 1 nearby lymph node and the 
melanoma in the lymph node is visible to the naked eye. 
 N2a: The melanoma has spread to 2 or 3 nearby lymph nodes and the 
melanoma in the lymph node is only seen under the microscope. 
 N2b: The melanoma has spread to 2 or 3 nearby lymph nodes and the 
melanoma in the lymph node is visible to the naked eye. 
 N2c: The melanoma has spread to 2 or 3 nearby lymph nodes, or the 
melanoma has spread to very small areas of nearby skin, or has spread to 
skin lymphatic channels around the tumor. 
 N3: The melanoma has spread to 4 or more lymph nodes, or spread to 
lymph nodes that are clumped together, or spread to nearby. 
 
 The M category is based on whether the melanoma has metastasized to distant 
organs. 
 
 To assign an M value to a case of melanoma, the results of the chest x-ray, 
MRI, CT scan, and/or blood tests are assessed by a doctor.  The possible M 
values are as follows: 
 
■ MX: Presence of distant metastasis cannot be assessed. 
 M0: No distant metastasis. 
Figure 7 – Sentinel Node Biopsy 
 
How a sentinel lymph node biopsy is performed 
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 M1a: Distant metastases to skin or subcutaneous (below the skin) tissue or 
distant lymph nodes. 
 M1b: Cancer cells have metastasized to the lung. 
 M1c: Cancer cells have metastasized to other organs 
 
 To make staging information even more accessible, a technique called stage 
grouping is also used.  Stage grouping is a process where common combinations of the T, 
N, and M stages are combined into even simpler groups, and are labeled: I, II, III, or IV.  
In general, patients with a lower stage grouping will have a better chance of surviving 
their cancer.  The following are the stage groupings for melanoma as stated by the 
American Cancer Society's Guide to Understanding Melanoma [7]: 
 Stage 0 
Tis, N0, M0: The melanoma is in situ, meaning that it involves the epidermis but 
has not spread to the dermis (see Figure 8 [1]).  
 
 
 
 Stage IA 
T1a, N0, M0: The melanoma is less than 1.0 mm in thickness. It is not ulcerated, 
appears to be localized in the skin, and has not been found in lymph nodes or 
distant organs (see Figure 9 [1]). 
 
 Stage IB 
T1b or T2a, N0, M0: The melanoma is less than 1.0 mm in thickness and is 
ulcerated or, or it is between 1.01 and 2.0 mm and is not ulcerated. It appears to 
be localized in the skin and has not been found in lymph nodes or distant organs 
(see Figure 9 [1]). 
Figure 8 – Stage 0 Melanoma 
 
The appearance of stage 0 melanoma 
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 Stage IIA 
T2b or T3a, N0, M0: The melanoma is between 1.01 mm and 2.0 mm in 
thickness and is ulcerated, or it is between 2.01 and 4.0 mm and is not ulcerated. 
It appears to be localized in the skin and has not been found in lymph nodes or 
distant organs (see Figure 10 [1]). 
 
 
 
 Stage IIB 
T3b or T4a, N0, M0: The melanoma is between 2.01 mm and 4.0 mm in 
thickness and is ulcerated, or it is thicker than 4.0 mm and is not ulcerated. It 
appears to be localized in the skin and has not been found in lymph nodes or 
distant organs (see Figure 10). 
 
Figure 10 – Stage II Melanoma 
 
The appearance of stage II melanoma 
Figure 9 – Stage I Melanoma 
 
The appearance of stage I melanoma 
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 Stage IIC 
T4b, N0, M0: The melanoma is thicker than 4.0 mm and is ulcerated. It appears 
to be localized in the skin and has not been found in lymph nodes or distant 
organs (see Figure 10). 
 
 Stage IIIA 
T1a-4a, N1a or N2a, M0: The melanoma is not ulcerated. It has spread to 1-3 
lymph nodes near the affected skin area, but the nodes are not enlarged and the 
melanoma is found only when they are viewed under the microscope. There is no 
distant metastasis. The thickness of the melanoma is not a factor (see Figure 11 
[1]). 
 
 
 
 Stage IIIB 
T1b-4b, N1a or N2a, M0: The melanoma is ulcerated. It has spread to 1-3 lymph 
nodes near the affected skin area, but the nodes are not enlarged and the 
melanoma is found only when they are viewed under the microscope. There is no 
distant metastasis. 
 
T1a-4a, N1b or N2b, M0: The melanoma is not ulcerated. It has spread to 1-3 
lymph nodes near the affected skin area. The nodes are enlarged because of the 
melanoma. There is no distant metastasis. 
 
T1a/b-4a/b, N2c, M0: The melanoma can be ulcerated or not. It has spread to 
small areas of nearby skin or lymphatic channels around the original tumor, but 
the nodes do not contain melanoma. There is no distant metastasis. 
 
 
 
Figure 11 – Stage III Melanoma 
 
The appearance of stage III melanoma 
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 Stage IIIC 
T1b-4b, N1b or N2b, M0: The melanoma is ulcerated. It has spread to 1 to 3 
lymph nodes near the affected skin area. The nodes are enlarged because of the 
melanoma. There is no distant spread. 
 
Any T, N3, M0: The melanoma can be ulcerated or not ulcerated. It has spread to 
4 or more nearby lymph nodes, or to nearby lymph nodes that are clumped 
together, or it has spread to nearby skin or lymphatic channels around the original 
tumor and to nearby lymph nodes. The nodes are enlarged because of the 
melanoma. There is no distant metastasis. 
 
 Stage IV 
Any T, Any N, M1: The melanoma has spread beyond the original area of skin 
and nearby lymph nodes to other organs such as the lung, liver, or brain, or to 
distant areas of the skin or lymph nodes. Neither the lymph node status nor 
thickness is considered, but typically the melanoma is thick and has also spread to 
lymph nodes (see Figure 12 [11]). 
 
 
 
 Other factors that affect the prognosis and treatment decisions for melanoma are 
the location of the tumor on the body, the mitotic index of the cancer cells, the presence 
Figure 12 – Stage IV Melanoma 
 
The appearance of stage IV melanoma 
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of tumor infiltrating lymphocytes, and the number of regional lymph nodes involved [11].  
After all these factors have been considered, a course of treatment can be chosen. 
 
Current Treatment Options for Melanoma 
 
 The current treatment methods for melanoma will now be discussed. Knowledge 
of these methods will become important when discussing the possibility of using 
radiofrequecy tissue ablation to treat melanoma in the “Next Steps: Diagnose and Treat 
Melanoma” section. 
The cure rate for melanoma is directly related to the stage of the cancer and the 
treatment used [13].  Once melanoma has been properly diagnosed and staged by a 
physician, a course of treatment can be chosen.  The type of treatment that is used to treat 
the cancer depends on the stage of the melanoma.  The most common method of 
treatment for melanoma is surgery to physically remove the cancer cell, chemotherapy, 
immunotherapy, or radiation therapy.  A combination of multiple methods may also be 
used.   
 Surgery to remove the tumor is the most common method of treatment for 
melanoma [12].  Surgery is also the popular method of treatment when the melanoma is 
still in the early stages of growth.  A surgeon may use a variety of techniques to 
physically remove the tumor from the body or to kill the cancer cells to stop them from 
spreading.  These techniques include: simple excision, electrodesiccation and curettage, 
Mohs surgery, and cryosurgery.   
Simple excision is similar to a biopsy.  A doctor cuts out the tumor using a scalpel, 
along with some surrounding healthy skin tissue [5].  Healthy tissue is also removed as a 
way to help assure that all the cancerous cells are removed.  If all the cancerous cells are 
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not removed, the melanoma may reappear.  The margin of how much healthy tissue is 
removed depends on how large the melanoma tumor is.  Table 1 shows the margin of 
healthy tissue removed in relation to how thick the original tumor is [7]: 
Table 1 – Tumor Excision Margins 
Tumor Thickness Margin of Healthy Skin Removed 
In situ .5 cm 
<1 mm 1 cm 
1 to 2 mm 1 to 2 cm 
2 to 4 mm 2 cm 
>4 mm At least 2 cm 
 
After the doctor removes the tumor, the skin is stitched back together at the 
surgery site.  A scar will often form in the place of the incision.  If a large amount of skin 
had to be removed, sometimes the doctor will perform a skin graft to cover the wound 
[7].  
 Another type of surgery to remove melanoma is called electrodesiccation and 
curettage.  With this technique, the doctor first cuts out the melanoma tumor using a tool 
called a curette; a small, sharp, spoon shaped tool.  The doctor then treats the area with 
electricity from a monopolar electrode to stop any bleeding and to kill any remaining 
cancer cells (see the “Monopolar versus Bipolar Electrodes” section for a discussion on 
how a monopolar tissue ablation system functions).  This process may then be repeated as 
necessary.  Like simple excision, electrodesiccation and curettage may leave a scar. 
 Mohs surgery is another type of surgery to remove melanoma.  It is a technique 
that can only be performed by specially trained physicians.  For this treatment method, 
the doctor first removes the visible tumor, while also only removing a very small margin 
of healthy skin (typically only 1 mm).  The removed skin is then sectioned, stained, and 
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examined under a microscope.  If cancer cells are detected in the sample, the doctor 
removes another thin slice of tissue in the area of where the cancer cells were seen.  The 
process is repeated until no cancer cells can be identified under the microscope.  This 
technique is useful in that very little healthy tissue is removed, which leads to smaller 
scars (see Figure 13 for an example of a scar caused by Mohs surgery [photo courtesy of 
Marlene Stante]).  However, not all doctors can perform Mohs surgery [5].  
 
 Another technique used to treat skin cancer surgically is cryosurgery.  
Cryosurgery uses liquid nitrogen applied to the tumor to freeze the cancer cells (see 
Figure 14 [1]).  When the cells freeze, the water in the cytoplasm of the cells expands 
until the cell burst, killing the cell.  After the treated tissue thaws, blisters may form on 
the area of treatment.  Healing may take 1 to 2 months and a scar will likely form.  The 
treated area will also have less pigmentation once the skin heals [5]. 
Figure 13 – Mohs Surgery Scar 
 
The scar left on a patient as a result of Mohs surgery 
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Chemotherapy is a type of treatment used to treat melanoma that has progressed 
further than the early stages and to other areas of the body.  Chemotherapy uses anti-
cancer drugs to kill the cancer cells.  There are three ways that the anti-cancer drugs can 
be administered to the patient: orally, intravenously, or through a technique called 
isolated limb perfusion.  In isolated limb perfusion, blood flow to the arm or leg that has 
the melanoma is stopped using a tourniquet.  The cancer drug is then injected into the 
limb.  This technique allows the drug to be given in higher doses, reach the tumor site 
more directly, and to stay in the area for a longer period of time.  No matter what delivery 
method is used, the anti-cancer drug travels through the blood stream and reaches all 
parts of the body.  This means that chemotherapy can affect the entire body, not just the 
tumor site.  The most common anti-cancer drugs used in chemotherapy are Dacarbazine, 
Figure 14 – Cryosurgery 
 
An example of using cryosurgery to treat 
skin cancer 
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Cisplatin, Vinblastine, DTIC, Temozolomide, and Paclitaxel [12].  These drugs may be 
administered by themselves or in combination with the other drugs.  The drugs function 
by attacking cells that divide quickly, such as cancer cells.  The drugs interfere with the 
cancer cells' abilities to replicate, thus stopping growth and killing the tumor.  
Chemotherapy drugs cause side effects, such as: loss of appetite, nausea and vomiting, 
lowered resistance to infection (due to low white blood cell counts), easy bruising or 
bleeding (due to low blood platelets counts), fatigue (due to low red blood cells counts).  
Since the drugs effect cells in the body that divide quickly, hair loss can also occur  
because hair follicles contain cells that divide quickly [7].   
Immunotherapy is a type of cancer treatment that is often used alongside 
chemotherapy.  Like chemotherapy, immunotherapy is used for cases of melanoma that 
have progressed beyond the early stages.  Immunotherapy works to fight cancer by 
increasing the body's own immune response to kill cancer cells.  Two immunotherapy 
drugs that are used to treat melanoma are interferon-alpha and interleukin-2.  Both of 
these are a classification of drugs called cytokines, which are manmade versions of 
substances naturally found in the body.  The drugs function by activating the body's 
natural immune response to fight off a pathogen.  Because the drugs are released into the 
blood stream, they can be used to fight cancer cells throughout the body that may have 
spread from the original tumor.  Some side effects of immunotherapy drugs include: 
fever, chills, aches, severe tiredness, drowsiness, and low blood cell counts [7]. 
 Radiation therapy is the final method of treatment for melanoma.  Radiation 
therapy is usually reserved for cases of melanoma that have progressed to later stages and 
have metastasized to other tissues in the body.  Radiation might also be used alongside 
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surgery at the treatment site, in order to destroy any remaining cancer cells.  Radiation 
therapy uses high levels of ionizing radiation to kill cancer cells [7]. The side effects of 
radiation therapy to treat melanoma includes: red or dry skin and fatigue [12]. 
 These treatment options can often be effective in treating skin cancer, as long as 
the treatment starts at an early stage.  However, many of the treatment methods have 
undesirable side effects including: scarring of the skin, fatigue, loss of appetite, nausea 
and vomiting, lowered resistance to infection, easy bruising or bleeding, fever, chills, 
aches, severe tiredness, drowsiness, and low blood cell counts.  A new method of cancer 
treatment that can effectively treat skin cancer yet not cause these harmful side effects is 
desired by doctors and patients.  It may be possible that radiofrequency tissue ablation 
could be this treatment method.  For a further discussion about the future possibility of 
radiofrequency tissue ablation to treat skin cancer, please see the “Radiofrequency Tissue 
Ablation” section. 
 
Melanoma Statistics 
 
 This section will provide statistical data about the incidence, morbidity, and 
mortality of melanoma.  This section will also present incidence and mortality statistics 
for all types of cancer, in order to make a qualitative comparison with melanoma. 
 Cancer is the second leading cause of death in the United States (heart disease is 
the leading cause of death).  Cancer is the cause of 1 in every 4 deaths in the United 
States [9].  It is estimated that 565,650 people died from cancer in the United States in 
2008, which is approximately 1500 deaths from cancer per day [14].  Cancer was the 
cause of death for 7.6 million people throughout the world in 2007 [7].  The incident rate, 
which is the number of new diagnoses during a specific time frame, for all types of 
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cancer in 2008 was 745,180 for men and 692,000 for women [14].  The age adjusted 
incident rate, which is a method of standardizing the age of a population so populations 
of different average ages can be compared (since the patient’s age greatly effects the 
chance of diagnosis, populations with different average ages will have different incident 
rates), for all types of cancer based on data from 2001 to 2005 was 467.4 per 100,000 
men and women per year.  The median age at diagnosis is 67, while the median age at 
death from cancer is 73 [14].  Based on data from 2003 to 2005, 40.35% of men and 
women born today will be diagnosed with cancer during their lifetime.  The lifetime risk 
of an individual in the United States for developing and dying from cancer is 
approximately 50% for men and approximately 33% for women [9]. 
Cancer of the skin is the most common type of cancer.  Skin cancer (including 
basal and squamous cell cancer) accounts for approximately half of all cancers [5].  
Melanoma, as has been previously stated, is the most deadly type of skin cancer.  34,950 
men and 27,530 women were diagnosed with melanoma in the United States in 2008 
[14].  The percentage of people that develop melanoma has doubled in the last 30 years 
[12].  Melanoma is the 6th most common type of cancer for men, with melanoma 
accounting for 5% of all new cancer cases.  Melanoma is the 7th most common type of 
cancer for women, with melanoma accounting for 4% of all new cancer cases [9].  The 
age adjusted incident rate for melanoma based on data from 2001 to 2005 was 19.4 per 
100,000 men and women.  White males are the most likely group to be diagnosed with 
melanoma, with an incident rate of 28.5 per 100,000.  1.81% of people born today will be 
diagnosed with melanoma sometime during their lifetime [14].  Males have a 2.42% 
chance of developing melanoma during their lifetime, while females have a 1.63% 
29 
 
chance of developing melanoma during their lifetime.  In the United States, California 
has the greatest number of new cases.  It is estimated that in California there were 7,620 
new diagnoses of melanoma in 2008 [9].  The median age at diagnosis for melanoma is 
59.  The prevalence of melanoma, which is the number of people who are alive today and 
have a history of the disease, is 723,416  [14]. 
 Once melanoma has been diagnosed, the most important factor that affects the 
patient's chance of survival is the thickness of the tumor.  Melanoma tumors that are less 
than 1mm in thickness have a 10 year survival rate of 95%, which is the patient’s chance 
of surviving 10 years after diagnosis.  If the melanoma is diagnosed later, the tumor will 
have had time to grow and spread, and the 10 year survival rate decreases.  A tumor that 
is 1 mm to 2 mm thick has a 10 year survival rate of 80%.  Tumors with a thickness of 2 
mm to 4 mm have a 10 year survival rate of 55%.  If that tumor is larger than 4 mm, the 
10 year survival rate drops to 30% [15].  Similar to tumor thickness, melanoma survival 
rates are also affected by what stage the cancer is in when it is diagnosed.  Table 2 shows 
the survival rates for melanoma by stage [7]: 
Table 2 – Melanoma Survival Rates by Stage 
 5 year (%) 10 year (%) 
IA 99 97 
IB 92 86 
IIA 78 66 
IIB 68 59 
IIC 56 48 
IIIA Not Available Not Available 
IIIB 50-68 44-60 
IIIC 27-52 22-37 
IV 18 14 
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As the table shows, as melanoma spreads and progresses, it becomes more 
difficult to treat, and the chance of survival is reduced.  Eighty percent of melanoma is 
diagnosed in the localized stage, which helps to keep deaths from melanoma low 
compared to the number of diagnoses and to other cancers [9].  The mortality of 
melanoma, which is the number of deaths during a specific time frame, in 2008 was 
8,420 men and women.  Melanoma accounts for less than half of all new skin cancer 
cases but causes the majority of deaths [7]. 
 Melanoma not only takes lives, but also puts a very large burden on the economy.  
It is estimated that the cost of cancer was $219.2 billion in 2007 [9].  This includes direct 
medical costs toward fighting cancer, lost productivity costs due to illness from cancer, 
and lost productivity costs due to premature death from cancer.  Eighty-nine billion 
dollars was spent in 2007 toward diagnosing and treating cancer.  It is very important to 
diagnose melanoma early since the stage of the cancer at the time of diagnosis greatly 
affects the patient’s chance of survival.  Since all of the current melanoma diagnosis 
techniques involve invasive procedures, doctors may be unwilling to perform biopsies on 
nevi that only have a slight chance of being cancerous.  This may allow for some 
melanoma to “slip through the cracks” and progress to later stages when they could have 
been diagnosed earlier.  A non-invasive diagnosis technique is needed.  Diagnosing 
melanoma by comparing the electrical properties of the suspected tumor to known values 
of healthy and cancerous skin may be able to fill this need, and is the main objective of 
this thesis. 
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Electrical Properties of Skin 
 
Introduction to Electrical Properties 
 
 This section will give an overview of the electrical properties of skin tissue.  Since 
the new technology for the diagnosis of skin cancer investigated in this thesis and the 
future research into radiofrequency tissue ablation will use electricity, it will be important 
to understand how the skin conducts electricity.  It will also be important to have an 
understanding of the electrical properties of cancer.  Using information on the differences 
between the electrical properties of healthy skin tissue and cancer will allow a device to 
detect skin cancer and also assist in treating the cancer with radiofrequency tissue 
ablation. 
 It will be helpful to have an understanding on the electrical properties terms that 
are discussed in this thesis.  Resistance is a measure of the amount of resistance to current 
flow through a material when a given voltage gradient is applied.  Resistance of a 
material is determined by the number of free electrons and ions available to flow through 
the material and act as charge carriers.  Capacitance is the ability of a material to hold a 
charge when a voltage gradient is applied.  When the voltage source is removed, the 
voltage difference between the two areas remains and begins to decay at a rate 
determined by the material properties and structure.  Impedance is a measure of a 
material’s resistance to an applied alternating current.  It is a combination of resistance 
and reactance (which is a method of measuring capacitance at certain frequencies, see 
Equation 3). 
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Physical Makeup and Electrical Properties 
 
The electrical properties of biological tissues result from the interaction of the 
applied electromagnetic radiation and the constituents of the tissue at the cellular and 
molecular level [16].  The relative amounts and positions of the tissues on the micro scale 
and their specific resistances to high frequency current control the current distribution of 
the tissue on the macro scale [17].  Three other factors that greatly affect the electrical 
properties of tissue include: the polarization of water molecules, the polarization of cell 
membranes which act as barriers to the flow of ions in and out of the cell, and ionic 
diffusion through the cellular membrane [16].   
 
Electrical Properties of Skin 
 
 Human skin tends to have high electrical impedance compared to other biologic 
tissues due to the properties of the stratum corneum [18].  It has been shown that skin has 
a statistically higher impedance than the other tissues of the body [19].  These higher 
impedances are caused by lower water content and the physical structure of the stratum 
corneum compared to other tissues. 
The stratum corneum is believed to have high impedance because of the low 
water content of the tissue compared to other tissues in the body.  Tissues with a similar 
amount of water content have been shown to have similar resistivities [19].  Water and 
the ions that are suspended in it, act as a medium that allows for current to flow.  When 
water content goes down in a tissue, the ability for that tissue to transport an electrical 
current diminishes.  As a result, the resistance of that tissue increases.  
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 In addition to effecting the resistive properties of skin, water also affects the 
capacitive properties.  Capacitance of skin also increases with increasing water content 
[20].  Previous research has shown that the capacitor properties of the stratum corneum 
are completely dependent on the amount of contained water.   When the stacked structure 
of skin cells becomes hydrated, the tissue acts like a capacitor because of the presence of 
layers of phospholipid membranes.   
Research has also found that the impedance of skin decreases as deeper layers of 
the stratum corneum are exposed.  This is because the water content of the skin increases 
with an increasing depth from the surface.  However, even at the same depth, not all skin 
has uniform impedance properties.  Skin lesions, along with the limbs of the body, have 
lower water content, and thus higher impedances [18].  The water content of skin can 
vary with the seasons, time of day, and temperature [21]. 
 Along with the amount of water in the tissue, the physical structure of the tissue 
can have an impact on the ability of current to flow, and thus influence the electrical 
properties of the tissue.  An example of the physical structure of a tissue affecting the 
electrical properties of that tissue is muscle fibers.  Muscle cells have an elongated shape, 
filled with cytoplasm.  They are bundled into larger structures called fibers.  The 
cytoplasm acts as an electrolyte and makes the fibers analogous to bundles of conducting 
wire.  Because of this structure, muscle fibers have a much lower resistance in the 
direction of the fibers relative to the resistance across the fiber [22].  This suggests that 
biologic tissues can have different electrical properties depending on the direction of the 
measurement relative to physical structures.  The physical structure of tissues also 
account for the high impedances observed.  Each cell in a biologic tissue has a radius of 
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approximately 10 nanometers, and each has its own intrinsic resistance and capacitive 
properties.  When a measurement of a 1 centimeter long sample is taken, approximately 
1,000 cells are connected in series.  The resistance of the entire sample increases by a 
factor of 1,000 while the capacitance is reduced by a factor of 1,000 (since capacitor 
elements add up inversely), compared to the original cell [10]. 
 The electrical properties of skin can be modeled as an equivalent circuit of a 
parallel resistor and capacitor.  Although, since the skin is non-uniform, when a voltage is 
applied the current flow is also non-uniform.  The resistor of the equivalent circuit can be 
seen as an ionic conductor with a resistance that falls as the number of charge carriers 
increase [23].   
 
Electrical Properties of Cancer 
 
Along with an understanding of the electrical properties of normal, healthy skin, it 
is also important to have an understanding of the electrical properties of cancerous 
tumors.  Knowing how the electrical properties of cancer differ, if at all, from healthy 
tissue, will allow one to be more confident in the data and conclusions that are presented 
later in this thesis. 
The average cell radius of a cancerous tumor is lower than that of a healthy cell.  
This means that the cellular volume fraction of a tumor is higher than normal tissue.  
Tumors also have an increased amount of epithelial cells.  The increase of cellular 
density and epithelial cells means that the amount of cytoplasm in a given amount of 
cancerous tissue increases.  Since cytoplasm is a good conductor because it allows the 
free flow of ions, the resistance of tumors decreases compared to normal tissue.  Tumors 
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also have an increased amount of extracellular fluid, which functions in a similar way to 
lower the resistance of the tumor [10].  
 
Practical Observations 
 
 From previous research into the electrical properties of biologic tissues, there are 
some interesting attributes of tissues that are good to keep in mind when taking 
measurements of the electrical properties of skin tissue.  The first is that the resistance of 
biological tissue is dependent on the frequency of which the measurement is taken at.  
Biologic tissue resistance has an inverse relationship with frequency [24].  As the 
frequency of the measurement signal increases, the resistance of the tissue decreases.  
This is due to the fact that at low frequencies, the ion densities around the area of the 
measurement probe increases, impeding the travel of current through the tissue.   The 
amount of the effect the frequency has on resistance has been quantified in previous 
research.  Resistivity decreases by 10-20% in an increase from 1 kHz to 10 kHz and 50%  
from 1 kHz to 100 kHz measurement frequency.   Conversely, resistivity rises 5% in a 
decrease in frequency from 1 kHz to 100 Hz and 20% in a change from 1 kHz to 10Hz 
[25].   
Another interesting attribute of the electrical properties of biologic tissue is that 
the resistance of biologic tissue increases with tissue necrosis.  This is caused by the fact 
that when a cell dies, the cell membrane loses its’ ability to maintain its’ insulating 
properties and ionic gradients [22].  Other research has confirmed this observation, noting 
that tissue undergoes large changes upon death of the cell, especially in low frequency 
ranges.  This is important to note because an electrical current will follow a path that 
offers the least resistance.  This holds true for when the current is passing through 
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biologic tissues, as a current that transverses a tissue sample will follow the path of least 
electrical resistance and will avoid tissues of higher resistance [17].  The fact that tissue 
impedance increases as cell necrosis progresses will be important to keep in mind in the 
“Radiofrequency Tissue Ablation,” as many radiofrequency ablation generators use this 
phenomenon to monitor the progress of treatment. 
 
Previously Recorded Values 
 
 When reporting values for the resistance of biologic tissues, researchers convert 
resistance values into units of resistivity, or specific resistance.  This converts the values 
from units of Ohms to units of Ohms*cm.  To make this conversion, Equation 1 is used 
[17]: 
Equation 1-Specific Resistance: 
 
RS = RM * SA / DE 
Where: 
  RS = Specific resistance 
  RM = Measured resistance 
  SA = Electrode surface area 
  DE = Distance between electrodes 
 
The purpose of making this conversion is to control for different-sized electrodes 
and electrode spacing that are used by different groups of researchers.  By reporting 
specific resistance instead of measured resistance, researchers are able to compare values, 
even though those values were recorded using different experimental setups.  There are 
two electrode setups that are used most commonly to determine the impedance of 
biologic tissues.  One system uses two electrodes, known as a Schwan electrode to drive 
a current through tissue and obtains measurements using the same two electrodes (see 
figure 15 [25]).  
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The other system uses four electrodes.  In the four electrode setup, the two outer 
electrodes drive a current through the tissue, while the two inner electrodes are the 
measurement electrodes (see Figure 16, where electrodes S1 and S2 drive the electrical 
current and electrodes m1 and m2 measure the electrical properties [25]).  Some believe 
that the 4 electrode system prevents polarization (or the buildup of ions) at the 
measurement electrodes which can lead to artificially higher values for the resistance.  
Other research has suggested that there is no significant difference between the two 
setups [24].  Other research has also found that the four electrode system does not 
eliminate polarization [25].  The electrode setup that was used by the author of this thesis 
most closely resembles the Schwan electrode.  
Figure 15 - Schwan Electrode 
 
An example of a Schwan electrode 
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Below are the summarized tissue resistance values found in the literature.  The 
values for muscle and fat are also included because they may be important to quantifying 
the electrical properties of a tumor that have advanced into deeper tissue.    The purpose 
of listing these previous measurements of the electrical properties of biologic tissues is to 
show that since there is little agreement among experts on the methods used and results 
obtained, it does not make sense to compare these measurements with data found during 
experiments performed for this thesis.  It is important to note that no previous research 
into the area of measuring the electrical properties of melanoma or comparing the 
electrical properties of normal and cancerous tissue was found in the literature. 
 Hemingway and McClendon found skin to have a specific resistance of 
289 Ohms*cm, fat to have a specific resistance of 2,180 Ohms*cm, and Muscle 
tissue to have a specific resistance of 110 Ohms using the 2 electrode setup and a 
frequency of 1MHz [17].  
 
 Geddes and Baker found that human muscle has a specific resistance of 
110 Ohms*cm at 1MHz (2-pp284).  They measured dog fat as having a specific 
resistance of 1500-3000 Ohms*cm at 10-100 kHz.  They also used a 2 electrode 
setup [22]. 
 
 Burger and VanDonger found that the specific resistance of muscle fibers 
varies by 3% between the longitudinal and transverse directions.  They found that 
on average, muscle fibers have a specific resistance of 675 Ohms*cm [24]. 
  
Figure 16 – 4 Electrode Tissue Probe 
 
A schematic of a 4 electrode 3 tissue probe 
39 
 
Gabriel and Corthout found that when measured at 10,000 Hz, human skin 
has a permittivity of 1E5 to 1E3 Farads/meter and a conductivity of 0.5E-1 to 1E-
4 Siemens/meter [16]. 
 
  Faes and Meij found skin to have a specific resistance of 329 Ohms*cm 
[20]. 
 
 One can see that there seems to be little agreement about the specific resistances 
of skin and other tissues.  This can be attributed to variations in the measurement 
apparati, measurement frequencies, and experimental procedures used by each researcher.  
Other factors such as in vivo versus in vitro, temperature, and time after excision could 
have caused the differences in results.  In addition, these measurements of tissue 
resistance were taken in order to learn about different characteristics of the tissue, such as 
hydration.  For some, the measurements were taken with the purpose of being compared 
to other tissues, instead of just investigating the properties of the tissue themselves.
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Experimental Methods 
 
Introduction to Experimental Methods 
 
 The following sections will outline the thought process and the steps that were 
taken in measuring the electrical properties of human skin analogues.  The purpose for 
measuring the electrical properties of human skin analogues is to illustrate  the concept 
that a bipolar measuring system can reliably distinguish between normal and cancerous 
skin tissue.   
 
Purpose of Measuring Electrical Properties of Skin Analogues 
 
 The purpose of measuring the resistance and reactance (which will also 
sometimes be referred to as, “electrical properties”) of skin analogues for this thesis is to 
attempt to conclude if skin with melanoma cells has a measurable difference of electrical 
properties compared to healthy, non cancerous skin.  If a difference can be reliably 
detected between the two tissue types, a device can be made that diagnoses cancer by 
measuring the electrical properties of the tissue.  Measurable different electrical 
properties could also let a device map out the border of the lesion against healthy tissue.  
Being able to map out the border of where healthy and cancerous tissue meet would 
allow the device to apply treatment only to the cancerous tissue and avoid an invasive 
procedure for both diagnosis and treatment. 
 A melanoma diagnosis system that functions by measuring the electrical 
properties of the suspected tumor is desirable because, as was shown earlier, all current 
diagnosis methods are invasive to the patient.  Surgery and scarring of the skin are a 
result of the melanoma diagnosis techniques.  A technique that compares the measured 
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electrical properties of the suspected tumor to known values of melanoma and healthy 
skin to make a diagnosis would be less invasive to the patient and cause no lasting 
effects. 
Experimental Measurement Materials 
 
 The following sections detail the experimental setups that were used for each 
experiment that was performed to gather data for this thesis.   
 
Electrode Fixture 
 
 Since the measured resistance and capacitance of a tissue sample is a function of 
the amount of tissue being measured (as evident by Equation 1), the distance between the 
electrodes must be the same for each trial.  In order to provide a consistent electrode 
setup for measuring the electrical properties of skin tissue analogues between samples 
and trials, an electrode fixture had to be designed and manufactured.  The fixture allowed 
the electrodes to be held at a consistent distance away from each other.   
 Several design considerations went into the design of the electrode fixture in order 
to ensure that the fixture functioned as needed.  These considerations included: ease of 
manufacture, material, suitable dimensions, ability of replace electrodes as needed, and 
usability.   
In order to ensure that the electrode fixture could be easily and quickly 
manufactured, a cylindrical design was chosen, allowing the fixture to be made on a 
lathe.  The main body of the fixture consists of a solid cylinder with a post protruding 
from one face (see part labeled 1 on Figure 17).  Through the body of the cylinder are two 
through holes that allow the wires of the electrodes to pass though.  A cylindrical tube 
goes over the post (see part labeled 2 on Figure 17).  This tube has two grooves on the 
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inner diameter where the electrodes are held.  Screws on the tube allow the tube to be 
tightened onto the post; securing the electrodes in place and also allowing the tube to be 
removed to access the electrodes (see Figure 18 for a picture of the fixture with 
electrodes).  The ability of the electrode holding tube to be able to slide off the body of 
the fixture allowed the electrodes to be easily replaced in the event of breakage.  
SolidWorks drawings of the electrode fixture can be found in the Appendix. 
 
  
The electrode fixture is made out of delrin.  Delrin was chosen because it is non-
conductive and would not interfere with the electrical measurements.  Delrin is also 
inexpensive which allowed for the costs associated with this thesis to be kept low.  Other 
benefits of using delrin include allowing the fixture to be non-corrosive and 
biocompatible. 
1 
2 
Figure 17 – Electrode Fixture 
 
The electrode fixture used to make electrical property measurements.  
The parts of the fixture are labeled 1 and 2. 
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Dimensions were chosen so that when the electrodes were inserted into the 
fixture, they would be spaced 1 cm apart.  This dimension was chosen to make it easy to 
convert the measured values into units of Specific Resistivity (Ohm-m).  Units of 
Specific Resistivity will allow the electrical property measurements found in the 
following experiments to be compared with data from the literature.  Using units of Ohm-
m cancel out any effects from the size of the specimen tested, and will give values that 
pertain to the inherent electrical properties of the material being tested.  An electrode 
spacing of 1 cm also allows the electrodes to be close enough to measure the tissue 
analogues that are to be used.  Too great of a distance between the electrodes could also 
cause unnecessarily high resistance measurements, since more material would be taken 
into account during the measurement, which could lead to measurement errors.  All the 
other dimensions were chosen to minimize the amount of material necessary to make the 
fixture but still allow it to be usable.   
Figure 18 - Electrode Fixture with Electrodes 
 
A picture of the electrodes in the electrode fixture 
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After preliminary tissue and equipment validation measurements were made, it 
became apparent that it would be helpful if the electrode fixture was attached to another 
fixture that would lower it and the electrodes down onto the sample and hold it steady.  
This would allow the same pressure to be placed on the sample for each trial, and keep 
the electrode fixture from moving during the measurement.  A height gauge was modified 
for this purpose.  The electrode fixture was secured to the height gauge, which could then 
be lowered onto the tissue sample (see Figure 19).   Since the electrode fixture was not 
secured in the vertical direction, the electrodes could only be pushed into the sample with 
the weight of the electrode fixture.  This allowed the pressure of the electrodes on the 
sample to be consistent for each measurement.  
 
Figure 19 – Height Gauge 
 
The height gauge after it was modified 
to hold the electrode fixture 
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Measurement Electrodes 
 
 The electrodes that were used to make electrical properties measurements of the 
skin analogues were made of a Silver-Chloride (AgCl) compound (see Figure 20).  AgCl 
electrodes are the most common type of electrode used when taking electrical 
measurements of biologic tissue because the compound does not create a charge density 
around the electrode.  A charge density occurs when ions in the sample are attracted to the 
electrode due to the alternating current.  These ions accumulate at the electrode-tissue 
interface, and interfere with the measurement. AgCl electrodes are also commonly used 
to make biologic measurements because they themselves do not exhibit polarization 
when a voltage is applied. 
  
Figure 20 – AgCl Electrodes 
 
The electrodes used to perform electrical property measurements 
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The AgCl electrodes that were chosen for this thesis were Warner Instruments 
pellet electrodes, model E255.  This electrode was chosen because it had the smallest 
diameter available (0.8 mm).  A small diameter allows the electrodes to make more 
accurate measurements because less tissue is under the electrode and a smaller area of 
tissue is between the two electrodes (see Equation 1).  The smaller measurement area 
allows for the measurement resolution to be increased and also prevents too large of 
values from being measured.  The electrodes are also described as “suitable for probing 
tissue” by the manufacturer.   
 Because the electrodes have a small diameter, they were brittle and subject to 
bending and breaking.  When this occurred, the broken electrodes were switched out for 
new electrodes.  This was facilitated by the fixture designed to allow the switching of 
electrodes. 
 A bipolar, 2-electrode setup was used for several reasons.  As it has been stated 
earlier, and will be further explored later in the “Next Steps” section of this thesis, part of 
the objective of this thesis was to investigate the possibility of using bipolar 
radiofrequency tissue ablation to treat skin cancer.  If the cancer is going to be treated 
with a bipolar setup, it would be beneficial to also diagnose the cancer in the same 
fashion.  Bipolar electrodes also provide other benefits for making measurements.  A 
bipolar setup only measures the tissue directly in-between the electrodes.  This leads to 
more accurate measurements and thus a more accurate diagnosis because only the 
suspected cancerous tissue in question is examined.   
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National Instruments ELVIS 
 
 To perform the actual measurements of electrical properties for this thesis, a 
National Instruments Educational Laboratory Virtual Instrumentation Suite (or ELVIS) 
was used.  ELVIS is a data acquisition device that uses a combination of hardware and 
software to allow the user to perform experiments that require measurements, 
automation, and control [26].  To perform the experiments in this thesis without ELVIS 
would have required the additional purchase of a separate power generator, oscilloscope, 
and function generator.  Instead, ELVIS uses virtual equivalents of these built into the 
software, with a bench-top breadboard to allow the physical experimental materials to 
interface with the software.  This allowed the costs of running these experiments to be 
greatly reduced. 
  The data acquisition device that was used for this thesis was the Impedance 
Analyzer.  The NI ELVIS Impedance Analyzer can measure the specific impedance 
characteristics, which is a combination of resistance and reactance, of the device or 
material being tested.  The NI ELVIS system accomplishes this by imputing an AC sine 
wave current source from the CURRANT HI pin to “excite” the material.  The resulting 
sine wave is measured on the CURRANT HI and CURRANT LOW pins and then broken 
down into: phase, magnitude, resistance, and reactance of the material [26].  A sample 
output is shown in Figure 16. NI ELVIS system allows a researcher to easily investigate 
the electrical properties of a sample by inserting the electrodes into the CURRANT HI 
and CURRANT LOW pins, creating a Schwan electrode setup.  All the researcher must 
do is select the measurement frequency. 
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 The Impedance Analyzer allows for the user to select the frequency for the AC 
sine wave currant source.  A value of 10 kHz was chosen to perform these experiments 
because it was the highest possible value that could be produced by the NI ELVIS 
system.  A high value was chosen because tissue ablation often uses signals in the 100s 
kHz range (see the “Tissue Ablation” section for more), and it was believed to be helpful 
to perform the measurements at a frequency similar to possible ablation frequencies.  A 
high frequency was also chosen because higher frequencies are better at preventing 
charge densities from building up in the material and result in lower impedances in 
biologic tissues. 
 For each measurement, the Impedance Analyzer was turned on, the bipolar 
electrodes placed on the sample, and then the signal output would be allowed to settle.  
This settling could take anywhere from 10-30 seconds.  Once the output had resolved, the 
resistance and reactance would be recorded, along with a screen shot of the graphical 
output (see Figure 21 for an example of the graphical output) for archiving.   
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 Reactance and resistance are the two components that make up a material's 
electrical impedance.  Resistance is the material's opposition to current flow on the real 
number line, and is measured in Ohms.  Reactance is the material's opposition to current 
flow on the imaginary number line, and is also measured in Ohms.  Resistance and 
reactance can be used to find a material's total impedance (also with units of Ohms) using 
Equation 2: 
Equation 2-Impedance as a Function of Resistance and Reactance: 
 
I = (R2 + Xr2)1/2 
Where: 
  I = Impedance 
  Xr = Reactance 
  R = Resistance 
 
Figure 21 – Sample ELVIS Output 
 
An example output of the ELVIS impedance analyzer 
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 Therefore, a material's impedance can be seen as the magnitude of the resistance 
and reactance, separated by an angle, or phase shift.  The capacitance of a material can be 
found if the reactance and measurement frequency are known using Equation 3: 
Equation 3-Capacitance as a Function of Frequency and Reactance: 
 
C = -1 / (2 * pi * F * Xr) 
Where: 
  C = Capacitance 
  Xr = Reactance 
  F = Frequency 
 
Validation and Experimental Samples 
 
 The main purpose of this thesis is to investigate a new method of skin cancer 
diagnosis.  This method would involve measuring the electrical properties of the suspect 
tumor, comparing it to known average values of healthy skin tissue and cancerous skin 
tissue, and making a diagnosis based on the results of the comparison.  In order to decide 
if this is a viable diagnosing method, it must be first established that there is a measurable 
difference between healthy skin and cancerous skin.  This will be the main objective for 
the experiments of this thesis: to build a database of the electrical properties of healthy 
and cancerous tissue, and to determine if there is a statistical difference between the two 
groups.  To do this analysis, experiments were performed with the previously mentioned 
fixture, electrodes, and data acquisition device on tissue samples to determine if a 
difference between the electrical properties of the samples could be seen.  The following 
section will outline the different samples tested and the reasoning behind why there were 
chosen.  Some of the samples were tested to first validate the experimental methods and 
NI ELVIS system, while other samples were tested for the purpose of creating the 
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aforementioned database.  To see the results of the experiments, please see the section 
titled “Data.” 
 
Elvis Validation 
 
 The purpose of the first experiments performed for this thesis was to validate the 
ELVIS system.  The author wanted to make sure that the values reported by the ELVIS 
system were accurate over the range of impedance values expected to be seen with tissue.  
This validation was performed by measuring various resistors and capacitors and 
comparing the measured values to the stated values of the circuit elements.  The circuit 
elements were plugged directly into the CURRANT OUT and CURRANT IN pins (the 
electrode fixture and electrodes were not used) on the ELVIS data acquisition device and 
the impedance analyzer was used at a frequency of 10 kHz.  The values of the resistors 
tested were: 10, 100, 1,000, 10,000, 100,000, and 1M Ohms.  Three different resistors for 
each value were tested.  The values for the capacitors tested were: 1E-5, 1E-6, 1E-7, 1E-
8, and 1E-9 Farads.  Three different capacitors for each value were tested.    It should be 
noted that all the circuit elements had a stated error of +/- 5% by the manufacturer. 
 
Bipolar Electrode and Electrode Fixture Validation 
 
 The purpose of the next experiments that were preformed was to validate the 
experimental setup of the silver-chloride bipolar electrodes, electrode fixture, and ELVIS 
system.   This validation experiment was also performed to ensure that the small size of 
the AgCl electrodes would not skew the electrical property measurements.  This 
experiment was performed in a similar manner to the ELVIS validation experiments, by 
measuring sets of resistors and capacitors, and comparing the measured values to the 
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stated values of the circuit elements.  To perform these tests, the electrodes and electrode 
fixture were set up how they would be for a tissue sample test on the ELVIS data 
acquisition system and then the circuit elements were connected to the electrodes.  The 
values and number of resistors and capacitors tested was the same for the previous 
validation test.  
 
Raw Chicken 
 
 After the experimental system had been validated, the next set of experiments 
consisted of using the ELVIS data acquisition system, bipolar electrodes, and electrode 
fixture to measure the electrical properties of different tissue sections of a raw chicken 
thigh (see Figure 22).  The different sections of the chicken thigh that were tested were 
the skin, thigh meat, and fat.   The purpose of testing different types of tissues was to 
evaluate whether or not the experimental methods used could distinguish between 
different tissue types by measuring the electrical properties.  Granted, the physical and 
visual differences between chicken skin, fat, and thigh meat are quite large, but if the 
system can distinguish a difference between them by only examining their electrical 
properties, it may be possible that it can also distinguish a difference between healthy and 
cancerous skin tissue.  For the testing of raw chicken thigh meat, skin, and fat, each type 
of tissue was measured 10 times at 10 kHz.  After a measurement of one type was taken, 
the bipolar electrodes were moved to another area of the same tissue and the 
measurement repeated, until all 10 measurements had been recorded. 
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Raw Chicken versus Cooked Chicken 
 
 After the raw chicken electrical property measurements had been made, the 
chicken samples that were used were cooked in a convection oven for 35 minutes at 350 
degrees Fahrenheit.  The same measurements that were previously taken were repeated 
and recorded.  The purpose of cooking the chicken and retaking the measurements was 
that since a major contributor to the electrical properties of a biologic tissue (and one of 
the main differences between normal tissue and tumors) is the water content of the tissue, 
cooking the tissue should remove a large proportion of the water, causing the electrical 
property values to change.  These values were compared to the values obtained from the 
same tissue before the sample was cooked, to investigate if water content made a 
difference in the electrical properties.  This experiment allowed the researcher to validate 
that the experiment setup of ELVIS data acquisition system, bipolar electrodes, and 
electrode fixture could distinguish between the different sample types (raw fat vs. cooked 
fat, raw skin vs. cooked skin, raw thigh meat vs. cooked thigh meat). 
Figure 22 – Raw Chicken Measurements 
 
An example of a measurement being taken for 
raw chicken meat 
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Human Skin Analogues 
 
 The final set of experiments that were preformed for this thesis involved 
measuring the electrical properties of several skin tissue cultures from MatTek, Corp (see 
Figure 23).  Two different sets of skin tissue cultures were tested: normal skin tissue 
(EpiDermTM) and skin tissue with malignant melanoma integrated into the sample 
(MelanomaTM).  The purpose of testing two different sets of human skin cultures was to 
compare the results of the electrical property measurements for each set.  Since one set 
contains malignant melanocytes while the other does not, if a statistical difference can be 
found between the two sets, the objective of this thesis will have been met: that 
melanoma skin cancer can be diagnosed by measuring the electrical properties of the 
suspected tumor and comparing those values to known values of healthy skin and 
cancerous skin tissue. 
  
Figure 23 – Skin Analogue Measurements 
 
An example of an electrical property 
measurement for a skin tissue analogue 
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 EpiDermTM skin model cultures were obtained from MatTek Corp. to be used as a 
human skin analogue for healthy, non-cancerous skin.  EpiDermTM has many features that 
make it ideal for this purpose.  The cultures are made from normal human epithelial 
keratinocytes and take the form of 3-D, highly dimensional tissue (see figure 24).  The 
cultures are metabolically active and have an in vivo-like lipid profile.  The samples have 
been cultured on specially prepared cell culture inserts.  MatTek Corp. claims that 
EpiDermTM closely parallels human skin ultra structurally, and exhibits in vivo-like 
morphological and growth characteristics.   EpiDermTM consists of organized granular, 
spinosum, and basal tissue layers, similar to those found in vivo [27].  It is important to 
note that the EpiDermTM samples have an even distribution of cells, which is visible in 
the figure. 
  
Figure 24 - EpiDermTM Histology 
 
A slide of an EpiDermTM sample showing the 
different keratinocyte morphologies 
Stratum 
Corneum 
Stratum 
Basale 
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The electrical properties of nine EpiDermTM samples were measured, with each 
sample measured four times at a 90 degree rotation from each other.  A total of 36 
individual tests were used to build the database for “normal skin tissue”. 
  MelanomaTM skin model cultures were obtained from MatTek Corp. to be used as 
human skin analogues for cancerous skin.  MelanomaTM has many features that make it 
ideal for this purpose.  The cultures contain human malignant melanoma cells embedded 
in 3-D, highly differentiated and human-like structure (see figure 25).  The normal tissue 
that the melanoma is seeded in consists of human-derived epidermal keratinocytes and 
normal dermal fibroblasts, closely resembling the EpiDermTM samples.  These cells have 
been cultured to form a multilayered, highly differentiated epidermis.  The epidermis of 
the cultures consists of organized granular, spinosum, and basal epidermal layers, similar 
to those found in vivo.  Structurally, the model closely parallels the progression of 
melanoma in vivo.  The cultures also have a dermal component that is composed of a 
collagen matrix and human dermal fibroblasts [27].  It is important to note that unlike the 
EpiDermTM samples, the MelanomaTM samples do not have a uniform distribution of 
cells.  The melanoma cells project down into the dermal layer of the sample, similar to 
the progression of melanoma in vivo.  
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The electrical properties of six MelanomaTM samples were measured, with each 
sample measured eight times at a 45 degree rotation from each other.  A total of 48 
individual tests were used to build the database for “cancerous skin tissue”.  
 
Figure 25 - MelanomaTM Histology 
 
A slide of a MelanomaTM sample showing the different 
keratinocyte morphologies and melanoma cells 
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Data 
 
 After the validation and electrical property measurements were taken as outlined 
in the “Validation and Experimental Samples” section, the data was entered into Minitab 
for graphical and statistical analysis.  It was used to create the charts, graphs, and 
statistical hypothesis testing seen below.  The following sections will present the data 
gathered during the experiments.  For a discussion of the data and analysis, please see the 
“Conclusions” section. 
 
ELVIS Validation Results 
 
 Table 3 contains the measured data for the ELVIS validation for resistance.  The 
face value of each resistor is listed, along with the measured value for each resistor.  The 
3rd column shows the percent error of the measured resistance to the listed value of 
resistance.  The final column shows whether the experimental error falls within the 5% 
error that is reported by the manufacturer. 
Table 3 – ELVIS Resistance Validation Data 
Face Value of Resistor (Ohms) Measured Resistance (Ohms) Experimental Error (%) In Tolerance (Y/N) 
10 12.37 23.7 N 
10 12.44 24.4 N 
10 18.28 82.8 N 
100 101.19 1.19 Y 
100 101.11 1.11 Y 
100 100.17 0.17 Y 
1000 982.41 -1.759 Y 
1000 979.66 -2.034 Y 
1000 982.62 -1.738 Y 
10000 9840 -1.6 Y 
10000 9900 -1 Y 
10000 9810 -1.9 Y 
100000 97190 -2.81 Y 
100000 97720 -2.28 Y 
100000 97240 -2.76 Y 
1000000 360630 -63.937 N 
1000000 354960 -64.504 N 
1000000 366200 -63.38 N 
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Table 4 is the measured data for the ELVIS validation for capacitance.  The face 
value for each capacitor is listed, along with the measured reactance value for each 
capacitor.  The measured reactance values are then converted to capacitance using 
Equation 3 so the measured values can be compared to the listed capacitance of each 
capacitor.  The 4th column shows the experimental error of the measured capacitance to 
the listed capacitance.  The final column shows whether the experimental error falls 
within the 5% error that is reported by the manufacturer. 
Table 4 – ELVIS Capacitance Validation Data 
Face Value of 
Capacitor (F) 
Measured Reactance 
(Ohms) 
Calculated 
Capacitance (F) 
Experimental 
Error (%) 
In Tolerance 
(Y/N) 
1.00E-005 1.27E-002 -1.25E-03 -12631.89 N 
1.00E-005 3.51E-002 -4.53E-04 -4634.33 N 
1.00E-005 5.39E-002 -2.95E-04 -3054.97 N 
1.00E-006 -14.09 1.13E-06 12.96 N 
1.00E-006 -14.07 1.13E-06 13.12 N 
1.00E-006 -13.78 1.15E-06 15.50 N 
1.00E-007 -157.01 1.01E-07 1.37 Y 
1.00E-007 -165.36 9.62E-08 -3.75 Y 
1.00E-007 -149.69 1.06E-07 6.32 N 
1.00E-008 -1.60E+003 9.95E-09 -0.53 Y 
1.00E-008 -1.59E+003 1.00E-08 0.10 Y 
1.00E-008 -1.57E+003 1.01E-08 1.37 Y 
1.00E-009 -1.53E+004 1.04E-09 4.09 Y 
1.00E-009 -1.57E+004 1.01E-09 1.37 Y 
1.00E-009 -1.62E+004 9.82E-10 -1.82 Y 
 
Below are two graphs (Scatterplot of ELVIS Resistance Validation and Scatterplot 
of EVLIS Capacitance Validation) that show the measured ELVIS data for the resistors 
and capacitors versus the theoretical listed values for both resistance and capacitance.  
Where only one data point is visible is a result of a tight grouping of the data compared to 
the scale of the graph.   
Please note: the measured reactance of the 1.00E-005 capacitors was left out 
because the ELVIS machine could not properly measure such a strong capacitor.  
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Including this data on the graph would have made the graph difficult to read.  However, 
this data is still used in the analysis in the “Conclusions” section. 
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Bipolar Electrode and Electrode Fixture Validation Results 
 
 Table 5 contains the measured data for the electrode and fixture validation for 
resistance.  The listed value of each resistor is shown in column 1, along with the 
measured value for each resistor in column 2.  The 3rd column shows the experimental 
error of the measured resistance to the listed resistance.  The final column shows whether 
the experimental error falls within the 5% error that is reported by the manufacturer. 
 
Table 5 – Bipolar Electrode and Electrode Fixture Resistance Validation Data 
Resistor Face Value (Ohms) Measured Resistance (Ohms) Experimental Error (%) 
In Tolerance 
(Y/N) 
10 12.69 26.90 N 
10 12.9 29.00 N 
10 28.89 188.90 N 
100 101.57 1.57 Y 
100 101.36 1.36 Y 
100 100.5 0.50 Y 
1000 984.93 -1.51 Y 
1000 983.07 -1.69 Y 
1000 985.16 -1.48 Y 
10000 9860 -1.40 Y 
10000 9930 -0.70 Y 
10000 9840 -1.60 Y 
100000 95860 -4.14 Y 
100000 96250 -3.75 Y 
100000 95940 -4.06 Y 
1000000 215290 -78.47 N 
1000000 215560 -78.44 N 
1000000 215790 -78.42 N 
 
 Table 8 is the measured data for the electrode and fixture validation for 
capacitance.  The listed value for each capacitor is shown in column 1, along with the 
measured reactance for each capacitor in column 2.  The measured reactance values are 
then converted to capacitance so they can be compared to the listed capacitance of each 
capacitor.  The 4th column shows the experimental error of the measured capacitance to 
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the listed capacitance.  The final column shows whether the experimental percent error 
falls within the 5% error that is reported by the manufacturer. 
 
Table 6 – Bipolar Electrode and Electrode Fixture Capacitance Validation Data 
Capacitor Face 
Value (F) 
Measured Reactance 
(Ohms) 
Calculated 
Capacitance (F) 
Experimental 
Error (%) 
In Tolerance 
(Y/N) 
1.00E-06 -13.96 1.14E-06 14.01 N 
1.00E-06 -13.92 1.14E-06 14.34 N 
1.00E-06 -13.65 1.17E-06 16.60 N 
1.00E-07 -155.33 1.02E-07 2.46 Y 
1.00E-07 -163.78 9.72E-08 -2.82 Y 
1.00E-07 -148.08 1.07E-07 7.48 N 
1.00E-08 -1580 1.01E-08 0.73 Y 
1.00E-08 -1560 1.02E-08 2.02 Y 
1.00E-08 -1550 1.03E-08 2.68 Y 
1.00E-09 -14930 1.07E-09 6.60 N 
1.00E-09 -15370 1.04E-09 3.50 Y 
1.00E-09 -15810 1.01E-09 0.70 Y 
 
Below are two graphs (Scatterplot of ELIVS and Electrode/Fixture Resistance 
Validation and Scatterplot of ELVIS and Electrode/Fixture Capacitance Validation) that 
show the measured ELVIS and electrode/fixture data versus theoretical face values for 
both resistance and capacitance.  Where only one data point is visible is a result of a tight 
grouping of the data compared to the scale of the graph. 
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Raw Chicken Results  
 
 Below are the results from the electrical property measurements of raw 
chicken using the bipolar electrodes, electrode fixture, and ELVIS as outlined in the 
Scatterplot of ELVIS and Electrode/Fixture Resistance 
Validation 
 
Scatterplot of ELVIS and Electrode/Fixture Capacitance 
Validation 
 
64 
 
“Validation and Experimental Samples” section.  Table 7 contains the measured 
resistance, reactance, and calculated capacitance of raw chicken skin.  Table 8 contains 
the measured resistance, reactance, and calculated capacitance of raw chicken thigh meat.  
Table 9 contains the measured resistance, reactance, and calculated capacitance of raw 
chicken fat. 
Table 7 – Raw Chicken Skin Data 
Raw Chicken Skin  
Resistance (Ohms) 
Raw Chicken Skin  
Reactance (Ohms) 
Calculated Raw Chicken Skin  
Capacitance (F) 
4280 -267.12 5.96E-08 
3730 -244.66 6.51E-08 
3110 -192.55 8.27E-08 
3400 -251.03 6.34E-08 
3630 -353.94 4.50E-08 
4040 -435.22 3.66E-08 
4970 -569.07 2.80E-08 
4470 -366.45 4.34E-08 
3480 -296.9 5.36E-08 
3700 -428.73 3.71E-08 
 
 
Table 8 – Raw Chicken Thigh Meat Data 
Raw Chicken Thigh Meat  
Resistance (Ohms) 
Raw Chicken Thigh Meat  
Reactance (Ohms) 
Calculated Raw Chicken Thigh Meat  
Capacitance (F) 
2150 -335.22 4.75E-08 
1660 -254.2 6.26E-08 
1280 -195.71 8.13E-08 
2120 -388.78 4.09E-08 
1770 -320.58 4.96E-08 
1550 -260.78 6.10E-08 
1700 -345.63 4.60E-08 
1550 -297.47 5.35E-08 
1820 -392.4 4.06E-08 
2110 -493.7 3.22E-08 
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Table 9 – Raw Chicken Fat Data 
Raw Chicken Fat  
Resistance (Ohms) 
Raw Chicken Fat  
Reactance (Ohms) 
Calculated Raw Chicken Fat  
Capacitance (F) 
2920 -139.39 1.14E-07 
1920 -92.53 1.72E-07 
2130 -105.43 1.51E-07 
2180 -104.61 1.52E-07 
3720 -167.75 9.49E-08 
3310 -231.6 6.87E-08 
3190 -30.73 5.18E-07 
2830 -146.11 1.09E-07 
3690 -57.98 2.74E-07 
3530 -12.13 1.31E-06 
 
Table 10 contains the calculated impedance of each raw chicken tissue type using 
Equation 2. 
Table 10 – Raw Chicken Calculated Impedance 
Calculated Raw Chicken Skin  
Impedance (Ohms) 
Calculated Raw Chicken Thigh Meat  
Impedance (Ohms) 
Calculated Raw Chicken Fat  
Impedance (Ohms) 
4288.33 2175.98 2923.33 
3738.02 1679.35 1922.23 
3115.95 1294.88 2132.61 
3409.25 2155.35 2182.51 
3647.21 1798.8 3723.78 
4063.38 1571.78 3318.09 
5002.47 1734.78 3190.15 
4485 1578.29 2833.77 
3492.64 1861.82 3690.46 
3724.76 2166.99 3530.02 
 
The following boxplots show the resistance, reactance, and impedance of each 
raw chicken tissue compared to each other.  Boxplots break data up into quartiles.  The 
two vertical lines show the 1st and 4th quartiles, while the shaded box shows the 2nd and 
3rd quartiles.  The horizontal line through each box shows the 50th percentile, or the mean 
average.  Boxplots that are on a different horizontal level with each other would suggest 
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that different values are measured for each type of tissue, and thus a difference between 
the electrical properties between the tissues. 
The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat 
Resistance” shows the measured resistance data for raw chicken.  The average resistance 
measurements for skin, meat, and fat are: 3,881 Ohms, 1,771 Ohms, and 2,942 Ohms 
respectively. 
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The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat 
Reactance” shows the measured reactance data for raw chicken.  The average resistance 
measurements for skin, meat, and fat are: -340.6 Ohms, -328.4 Ohms, and -108.8 Ohms 
respectively. 
 
Boxplot of Raw Chicken Skin vs. Meat vs. Fat Resistance 
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The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat 
Impedance” shows the calculated impedance data for raw chicken using Equation 2.  The 
average impedance values for skin, meat, and fat are: 3,897 Ohms, 1,801 Ohms, and 
2,945 Ohms respectively. 
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Boxplot of Raw Chicken Skin vs. Meat vs. Fat Reactance 
 
Boxplot of Raw Chicken Skin vs. Meat vs. Fat Impedance 
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 The following scatterplot, “Scatterplot of Raw Chicken Skin vs. Meat vs. Fat 
Electrical Properties” shows each measurement for each raw chicken tissue sample on the 
same plot.  Separate grouping of the measurements would suggest that there are 
fundamental differences of the electrical properties between the tissue types. 
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A One-Way ANOVA (or Analysis of Variance) can be used to conclude whether 
data from two or more sets are statistically different from each other.  ANOVA returns a 
test statistic which can be used to reject or accept a null hypothesis.  
A One-Way ANOVA analysis was performed with Minitab on the raw chicken 
impedance data.  If by using the ANOVA analysis we can conclude that the tissues had 
statistically different electrical properties, we can conclude that the experimental setup 
was successful in detecting the different electrical properties of the tissues.  We may also 
conclude that different types of tissues have statistically different electrical properties.  
The Minitab output, along with the ANOVA p-value, is shown below.  A discussion about 
Scatterplot of Raw Chicken Skin vs. Meat vs. Fat Electrical Properties 
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what conclusions can be reached, if any, from this output will be discussed in the 
“Conclusions” section. 
One-way ANOVA: Skin Impedance (, Thigh Meat Imped, Fat Impedance (O 
 
Source  DF        SS        MS      F      P 
Factor   2  22003739  11001869  38.77  0.000 
Error   27   7662734    283805 
Total   29  29666472 
 
S = 532.7   R-Sq = 74.17%   R-Sq(adj) = 72.26% 
 
 
 
 
Level                      N    Mean  StDev 
Skin Impedance (Ohms)     10  3896.7  565.4 
Thigh Meat Impedance (Oh  10  1801.8  294.6 
Fat Impedance (Ohms)      10  2944.7  667.0 
 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level                     ---------+---------+---------+---------+ 
Skin Impedance (Ohms)                                   (----*----) 
Thigh Meat Impedance (Oh  (----*----) 
Fat Impedance (Ohms)                      (----*----) 
---------+---------+---------+---------+ 
2100      2800      3500      4200 
 
Pooled StDev = 532.7 
 
 
Cooked Chicken Results 
 
Below are the results from the electrical property measurements of cooked 
chicken using the bipolar electrodes, electrode fixture, and ELVIS as outlined in the 
“Validation and Experimental Samples” section.  Table 11 contains the measured 
resistance, reactance, and calculated capacitance of cooked chicken skin.  Table 12 
contains the measured resistance, reactance, and calculated capacitance of cooked 
chicken thigh meat.  Table 13 contains the measured resistance, reactance, and calculated 
capacitance of cooked chicken fat. 
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Table 11 – Cooked Chicken Skin Data 
Cooked  Chicken Skin  
Resistance (Ohms) 
Cooked Chicken Skin  
Reactance (Ohms) 
Calculated Cooked Chicken Skin  
Capacitance (F) 
6480 -742.27 2.14E-08 
6220 -665.59 2.39E-08 
5950 -804.37 1.98E-08 
9280 -848.65 1.88E-08 
12140 -991.42 1.61E-08 
12970 -2440 6.52E-09 
9270 -1530 1.04E-08 
6650 -1250 1.27E-08 
11400 -2040 7.80E-09 
3300 -468.88 3.39E-08 
 
Table 12 – Cooked Chicken Thigh Meat Data 
Cooked Chicken Thigh Meat  
Resistance (Ohms) 
Cooked Chicken Thigh Meat  
Reactance (Ohms) 
Calculated Cooked Chicken Thigh Meat  
Capacitance (F) 
2840 -670.08 2.38E-08 
2580 -624.3 2.55E-08 
2870 -771.73 2.06E-08 
3280 -733.05 2.17E-08 
2920 -764.47 2.08E-08 
2650 -781.86 2.04E-08 
2590 -715.52 2.22E-08 
2220 -642.91 2.48E-08 
2380 -821.99 1.94E-08 
2540 -724.78 2.20E-08 
 
Table 13 – Cooked Chicken Thigh Mean Data 
Cooked Chicken Fat  
Resistance (Ohms) 
Cooked Chicken Fat  
Reactance (Ohms) 
Calculated Cooked Chicken Fat  
Capacitance (F) 
22190 -1770 8.99E-09 
22220 -2310 6.89E-09 
26340 -5050 3.15E-09 
17010 -1690 9.42E-09 
34620 -1440 1.11E-08 
15930 -654.13 2.43E-08 
27670 -2380 6.69E-09 
32440 -513.76 3.10E-08 
28640 -3040 5.24E-09 
44280 -5390 2.95E-09 
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Table 14 contains the calculated impedance of each cooked chicken tissue type 
using Equation 2. 
Table 14 – Cooked Chicken Calculated Impedance 
Calculated Cooked Chicken Skin  
Impedance (Ohms) 
Calculated Cooked Chicken Meat  
Impedance (Ohms) 
Calculated Cooked Chicken Fat  
Impedance (Ohms) 
6522.37 2917.98 22260.48 
6255.51 2654.46 22339.75 
6004.12 2971.95 26819.73 
9318.72 3360.92 17093.75 
12180.42 3018.41 34649.94 
13197.52 2762.93 15943.42 
9395.41 2687.02 27772.17 
6766.46 2311.22 32444.07 
11581.09 2517.95 28800.89 
3333.1 2641.38 44606.84 
 
The following boxplots show the resistance, reactance, and impedance of each 
cooked chicken tissue compared to each other.  Boxplots that are on a different horizontal 
level with each other would suggest that different values are measured from each type of 
tissue, and thus a difference between the electrical properties between the tissues. 
The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat 
Resistance” shows the measured resistance data for cooked chicken.  The average 
resistance measurements for skin, meat, and fat are: 8,366 Ohms, 2,687 Ohms, and 
27,134 Ohms respectively. 
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The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat 
Reactance” shows the measured resistance data for cooked chicken.  The average 
reactance measurements for skin, meat, and fat are: -1,178 Ohms, -725.1 Ohms, and      -
2,424 Ohms respectively. 
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Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Resistance 
 
Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Reactance 
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The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat 
Impedance” shows the calculated impedance data for cooked chicken using Equation 2.  
The average impedance values for skin, meat, and fat are: 8,455 Ohms, 2,784.4 Ohms, 
and 27,273 Ohms respectively. 
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The following scatterplot, “Scatterplot of Cooked Chicken Skin vs. Meat vs. Fat 
Electrical Properties” show the measurements for each cooked chicken tissue sample on 
the same plot.  Separate grouping of the measurements would suggest that there are 
fundamental differences of the electrical properties between the tissue types. 
Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Impedance 
 
74 
 
50000400003000020000100000
0
-1000
-2000
-3000
-4000
-5000
-6000
Resistance (Ohms)
R
ea
ct
an
ce
 (
O
hm
s)
cooked skin reactance * cooked skin resistance
cooked meat reactance * cooked meat resistance
cooked fat reactance * cooked fat resistance
Variable
 
 
A One-Way ANOVA analysis was performed with Minitab on the cooked chicken 
impedance data.  If by using the ANOVA analysis we can conclude that the tissues had 
statistically different electrical properties, we can conclude that the experimental setup 
was successful in detecting the different electrical properties of the tissues.  We may also 
conclude that different types of tissues have statistically different electrical properties.  
The Minitab output, along with the ANOVA p-value, is shown below.  A discussion about 
what conclusions can be reached, if any, from this output will be discussed in the 
“Conclusions” section. 
 
 
 
 
 
 
Scatterplot of Cooked Chicken Skin vs. Meat vs. Fat Electrical Properties 
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One-way ANOVA: cooked skin impe, cooked meat impe, cooked fat imped  
 
Source  DF          SS          MS      F      P 
Factor   2  3286532094  1643266047  58.53  0.000 
Error   27   758069173    28076636 
Total   29  4044601267 
 
S = 5299   R-Sq = 81.26%   R-Sq(adj) = 79.87% 
 
 
 
 
Level                   N   Mean  StDev 
cooked skin impedance  10   8455   3187 
cooked meat impedance  10   2784    295 
cooked fat impedance   10  27273   8601 
 
                       Individual 95% CIs For Mean Based on 
                       Pooled StDev 
Level                  -+---------+---------+---------+-------- 
cooked skin impedance         (----*---) 
cooked meat impedance  (---*----) 
cooked fat impedance                                  (---*---) 
                       -+---------+---------+---------+-------- 
                        0      8000     16000     24000 
 
Pooled StDev = 5299 
 
 
Raw Chicken versus Cooked Chicken Results 
 
The following scatterplots compare the electrical properties for each chicken 
tissue type between raw and cooked chicken.  Again, separate groupings would suggest 
that the experimental system was able to determine a difference between the electrical 
properties that occurs when a biological tissue is cooked and the water content is 
lowered. 
The following scatterplot, “Scatterplot of Chicken Skin Raw vs. Cooked 
Electrical Properties” shows the measured reactance and resistance of raw and cooked 
chicken skin on the same graph.   
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The following scatterplot, “Scatterplot of Chicken Meat Raw vs. Cooked 
Electrical Properties” shows the measured reactance and resistance of raw and cooked 
chicken meat on the same graph. 
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Scatterplot of Chicken Skin Raw vs. Cooked Electrical Properties 
 
Scatterplot of Chicken Meat Raw vs. Cooked Electrical Properties 
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The following scatterplot, “Scatterplot of Chicken Fat Raw vs. Cooked Electrical 
Properties” shows the measured reactance and resistance of raw and cooked chicken fat 
on the same graph. 
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T-tests were performed using Minitab to compare the differences in raw and 
cooked chicken impedance results for each tissue type (skin, meat, and fat).  T-tests are 
used to conclude whether or not two groups of data are statistically different from each 
other.  T-tests are the equivalent of an ANOVA when data from only two set are being 
compared.  If by using a T-test we can conclude that each group of tissue (raw vs. 
cooked) is statistically different from each other, we can conclude that the experimental 
setup was successful in detecting the difference in electrical properties between the 
tissues based on water content.  We may also conclude that different types of tissues have 
statistically different electrical properties.  The Minitab output for each comparison, 
along with the T-test p-value, is shown below.  A discussion about what conclusions can 
be reached, if any, from this output will be discussed in the “Conclusions” section. 
Scatterplot of Chicken Fat Raw vs. Cooked Electrical Properties 
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Two-Sample T-Test and CI: skin impedance, cooked skin impedance  
 
Two-sample T for skin impedance vs cooked skin impedance 
 
                        N  Mean  StDev  SE Mean 
skin impedance         10  3897    565      179 
cooked skin impedance  10  8455   3187     1008 
 
 
Difference = mu (skin impedance) - mu (cooked skin impedance) 
Estimate for difference:  -4559 
95% CI for difference:  (-6875, -2243) 
T-Test of difference = 0 (vs not =): T-Value = -4.45  P-Value = 0.002  DF 
= 9 
 
Two-Sample T-Test and CI: thigh meat impedance, cooked meat impedance  
 
Two-sample T for thigh meat impedance vs cooked meat impedance 
 
                                          SE 
                        N  Mean  StDev  Mean 
thigh meat impedance   10  1802    295    93 
cooked meat impedance  10  2784    295    93 
 
 
Difference = mu (thigh meat impedance) - mu (cooked meat impedance) 
Estimate for difference:  -983 
95% CI for difference:  (-1261, -705) 
T-Test of difference = 0 (vs not =): T-Value = -7.45  P-Value = 0.000  DF 
= 17 
 
Two-Sample T-Test and CI: fat impedance, cooked fat impedance  
 
Two-sample T for fat impedance vs cooked fat impedance 
 
                       N   Mean  StDev  SE Mean 
fat impedance         10   2945    667      211 
cooked fat impedance  10  27273   8601     2720 
 
 
Difference = mu (fat impedance) - mu (cooked fat impedance) 
Estimate for difference:  -24328 
95% CI for difference:  (-30500, -18157) 
T-Test of difference = 0 (vs not =): T-Value = -8.92  P-Value = 0.000  DF 
= 9 
 
Human Skin Analogue Results 
 
 Table 15 contains the results from the electrical property measurements of 
EpiDermTM tissue sample from MatTek Corp. using the bipolar electrodes, electrode 
fixture, and ELVIS as outlined in the “Validation and Experimental Samples” section. 
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Table 15 – EpiDermTM Data 
Tissue Sample 
Resistance  
(Ohms) 
Reactance  
(Ohms) 
Calculated Impedance  
(Ohms) 
A 14350 -776.63 14371.00 
A 15030 -939.91 15059.36 
A 45330 -6460 45788.00 
A 30770 -2370 30861.14 
B 1920 -126.9 1924.19 
B 2680 -123.05 2682.82 
B 4440 -239.66 4446.46 
B 6670 -668.26 6703.39 
C 9640 -655.55 9662.26 
C 13340 -2300 13536.82 
C 7820 -359.14 7828.24 
C Not available Not available Not available 
D 5900 -460.65 5917.96 
D 6030 -449.12 6046.70 
D 6210 -362.41 6220.57 
D 6060 -423.76 6074.80 
E 1500 -93.05 1502.88 
E 1120 -109.88 1125.38 
E 2140 -231.09 2152.44 
E 1810 -168.81 1817.86 
F 21540 -1610 21600.09 
F 8820 -544.96 8836.82 
F 12680 -651.23 12696.71 
F 16790 -906.72 16814.47 
G 1790 -123.77 1794.27 
G 2110 -100.53 2112.39 
G 2160 -93.26 2162.01 
G 2150 -87.05 2151.76 
H 2990 -124.27 2992.58 
H 2340 -105.57 2342.38 
H 2500 -109.27 2502.39 
H 2210 -96.3 2212.10 
I 2470 -114.54 2472.65 
I 2390 -131.1 2393.59 
I 2170 -118.93 2173.26 
I 2180 -118.54 2183.22 
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 Below is the scatterplot, “Scatterplot of EpiDermTM Electrical Properties” that 
shows the measured electrical properties of the EpiDermTM samples. 
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Below is the Boxplot, “Boxplot of EpiDermTM Impedance” that shows the 
calculated impedance values for each EpiDermTM sample. 
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Scatterplot of EpiDermTM Electrical Properties 
 
Boxplot of EpiDermTM Impedance 
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 As one can see, there appear to be some outliers in the data that are skewing the 
results.  These data points (specifically samples: A, C, and F) have such a greater 
variance and average than the other samples, it can be assumed that errors occurred 
during the measurement of these samples.   These samples have averages that are more 
than two standard deviations from the mean of the rest of the data.  These errors could 
have be a result of the individual tissue samples drying out before they could be 
measured.  Since the samples were used in previous, unrelated experiments before given 
to the author, it is rational to assume that they had been compromised.  To stop these 
outliers from skewing the data and following analysis, they will be removed from the 
normal tissue dataset.  The modified EpiDermTM data that will be used for the remainder 
of this thesis is presented below in Table 16. 
 
Table 16 – EpiDermTM Data W/O Outliers 
Tissue Sample  
W/O Outliers (Ohms) 
Resistance  
W/O Outliers (Ohms) 
Reactance  
W/O Outliers (Ohms) 
Calculated Impedance  
W/O Outliers (Ohms) 
B 1920 -126.9 1924.189079 
B 2680 -123.05 2682.823383 
B 4440 -239.66 4446.463417 
B 6670 -668.26 6703.392531 
D 5900 -460.65 5917.955595 
D 6030 -449.12 6046.702306 
D 6210 -362.41 6220.565972 
D 6060 -423.76 6074.798148 
E 1500 -93.05 1502.88333 
E 1120 -109.88 1125.377099 
E 2140 -231.09 2152.441077 
E 1810 -168.81 1817.855004 
G 1790 -123.77 1794.273951 
G 2110 -100.53 2112.393496 
G 2160 -93.26 2162.012356 
G 2150 -87.05 2151.761535 
H 2990 -124.27 2992.581333 
H 2340 -105.57 2342.380205 
H 2500 -109.27 2502.386847 
H 2210 -96.3 2212.097125 
I 2470 -114.54 2472.654325 
I 2390 -131.1 2393.59295 
I 2170 -118.93 2173.256622 
I 2180 -118.54 2183.220495 
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Below is the scatterplot, “Scatterplot of EpiDermTM W/O Outliers Electrical 
Properties” that shows the resistance and reactance of the EpiDermTM samples with the 
outliers removed. 
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Below is the boxplot, “Boxplot of EpiDermTM W/O Outliers Impedance” that 
shows the calculated impedance values of the EpiDermTM samples with the outliers 
removed. 
Scatterplot of EpiDermTM W/O Outliers Electrical Properties 
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 Please note: from this point on, the EpiDermTM data will no longer be referred to 
with the qualifier “W/O outliers.” 
 Below in Table 17 are the results from the electrical property measurements of 
MelanomaTM tissue samples from MatTek Corp. using the bipolar electrodes, electrode 
fixture, and ELVIS as outlined in the “Validation and Experimental Samples” section. 
 
 
 
 
 
 
 
 
 
Boxplot of EpiDermTM W/O Outliers Impedance 
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Table 17 – MelanomaTM Data 
Tissue Sample Resistance (Ohms) Reactance (Ohms) Calculated Impedance (Ohms) 
Mel 1 21600 -5810 22367.75 
Mel 1 33480 -8800 34617.20 
Mel 1 25360 -9390 27042.59 
Mel 1 29890 -6940 30685.11 
Mel 1 28120 -9480 29674.99 
Mel 1 4710 -455.12 4731.94 
Mel 1 6390 -1030 6472.48 
Mel 1 24840 -10270 26879.33 
Mel 2 36340 -14300 39052.34 
Mel 2 4230 -303.68 4240.89 
Mel 2 4990 -776.39 5050.04 
Mel 2 5840 -754.28 5888.51 
Mel 2 5400 -597.93 5433.00 
Mel 2 5910 -926.34 5982.16 
Mel 2 4580 -485.33 4605.64 
Mel 2 4200 -352.69 4214.78 
Mel 3 26760 -6290 27489.30 
Mel 3 32940 -7010 33677.64 
Mel 3 37160 -10810 38700.41 
Mel 3 32750 -7360 33566.83 
Mel 3 37480 -9140 38578.36 
Mel 3 34780 -9020 35930.61 
Mel 3 35610 -6690 36232.97 
Mel 3 32520 -4330 32807.00 
Mel 4 767.78 -25.25 768.20 
Mel 4 887.54 -27.46 887.96 
Mel 4 941.05 -36.56 941.76 
Mel 4 1020 -35.98 1020.63 
Mel 4 1190 -39 1190.64 
Mel 4 1210 -46.54 1210.89 
Mel 4 1340 -61.87 1341.43 
Mel 4 1630 -102.43 1633.22 
Mel 5 1190 -86.14 1193.11 
Mel 5 1280 -95.35 1283.55 
Mel 5 1460 -121.03 1465.01 
Mel 5 1320 -100.92 1323.85 
Mel 5 1350 -100.07 1353.70 
Mel 5 1310 -104.23 1314.14 
Mel 5 1370 -113.21 1374.67 
Mel 5 1450 -126.97 1455.55 
Mel 6 5040 -659.75 5083.00 
Mel 6 4770 -580.54 4805.20 
Mel 6 11930 -3830 12529.72 
Mel 6 11180 -4180 11935.86 
Mel 6 11410 -4580 12294.90 
Mel 6 5920 -961.16 5997.52 
Mel 6 5560 -858.22 5625.85 
Mel 6 5080 -742.57 5133.99 
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Below is the scatterplot, “Scatterplot of MelanomaTM Electrical Properties” that 
shows the measured electrical properties of the MelanomaTM samples. 
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Below is the Boxplot, “Boxplot of EpiDermTM Impedance” that shows the 
calculated impedance values for each EpiDermTM sample. 
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Scatterplot of MelanomaTM Electrical Properties 
 
Boxplot of MelanomaTM Impedance 
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Comparison of MelanomaTM and EpiDermTM 
 
 For the following graphs and analysis, the data recorded from the measurement of 
MelanomaTM and EpiDermTM were added to the same Minitab file.  This allowed 
comparisons between the two sets of data.  Comparing the EpiDermTM and MelanomaTM 
data is the primary test performed for this thesis.  A statistical difference between the two 
sets of data would suggest that melanoma tissue can be distinguished from normal tissue. 
 Below is the scatterplot, “Scatterplot of EpiDermTM and MelanomaTM Electrical 
Properties” which shows the measured resistance and reactance values of the two 
different tissue types on the same graph. 
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Below is the boxplot, “Boxplot of EpiDermTM and MelanomaTM Impedance” 
which shows the measured calculated impedance values of the two different tissue types 
on the same graph.  The average impedance for EpiDermTM and MelanomaTM are: 3,088 
Ohms and 12,856 Ohms respectively. 
Scatterplot of EpiDermTM and MelanomaTM Electrical Properties 
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A One-Way ANOVA analysis was performed with Minitab on the EpiDermTM and 
MelanomaTM data.  If by using the ANOVA analysis we can conclude that the tissues had 
statistically different electrical properties, we can conclude that the experimental setup 
was successful in detecting the different electrical properties of the tissues.  We may also 
conclude that different types of tissues have statistically different electrical properties.  
The Minitab output, along with the ANOVA p-value, is shown below.  A discussion about 
what conclusions can be reached, if any, from this output will be discussed in the 
“Conclusions” section. 
One-way ANOVA: Impedance (Ohms) versus Sample  
 
Source  DF           SS          MS      F      P 
Sample   1   1526660835  1526660835  11.64  0.001 
Error   70   9184007210   131200103 
Total   71  10710668045 
 
S = 11454   R-Sq = 14.25%   R-Sq(adj) = 13.03% 
                            Individual 95% CIs For Mean Based on 
                            Pooled StDev 
Level      N   Mean  StDev  ---+---------+---------+---------+------ 
EpiDerm   24   3088   1736  (--------*---------) 
Melanoma  48  12856  13926                        (------*-----) 
                            ---+---------+---------+---------+------ 
                               0      5000     10000     15000 
Pooled StDev = 11454 
Boxplot of EpiDermTM and MelanomaTM Impedance 
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Conclusions 
 
 The following sections will discuss the data that was gathered from the 
experiments presented earlier in Table 3 through Table 17.  When possible, the author 
will come to a conclusion about what the data means in relation to the purpose of the 
experiment and the objective of this thesis: to build a database of the electrical properties 
of healthy and cancerous tissue, and determine if there are statistical differences between 
the two types. 
 
ELVIS Validation Discussion 
 
 The resistance and capacitance data gathered during the validation of the ELVIS 
data acquisition system was presented in Tables 3 and 4.  It is important that ELVIS 
accurately and precisely measured resistance and capacitance over a range of values that 
is possible with biologic tissues, since the system would be later used to measure chicken 
tissue and human skin analogues.   
 From the data in Table 3, ELVIS accurately measured the resistance of the 
resistors tested (within a 5% margin of error that was reported by the manufactures) 
between the values of 100 to 100k Ohms.  If the measured values of resistance of the 
different tissue values fell within this range, we can conclude that the ELVIS system can 
accurately measure resistance.  The measured resistance values for raw chicken fell 
between 1k and 5k Ohms, the measured resistance values of cooked chicken fell between 
2k and 50k Ohms, and measured resistance values of the EpiDermTM and MelanomaTM 
tissue analogues from MatTek Corp. fell between 1k and 40k Ohms.  Since all the 
measured tissue resistance values fell within the accurate range for ELVIS, we can be 
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confident in concluding that the ELVIS system accurately reported the resistance 
measurements that were inputted during these experiments. 
 Looking at the ELVIS validation data for capacitance in Table 4, one can see the 
ELVIS system accurately measured the reactance of the capacitors tested (within a 5% 
margin of error that was reported by the manufacturers) approximately between the 
values of -100 and -16k Ohms (remember reactance is on the imaginary plane for 
impedance, and a negative value for reactance converts to a positive value of capacitance.  
See Equation 3).  If the measured values of reactance of the different tissue values fell 
within this range, we can conclude that the ELVIS system can accurately measure 
reactance, and therefore capacitance.  The measured reactance values for raw chicken fell 
between -12 and -600 Ohms (with only 2 measurements out of 30 outside of the 
acceptable range), the measured reactance values of cooked chicken fell between -600 
and -5.5k Ohms, and the measured reactance values of the EpiDermTM and MelanomaTM 
tissue analogues from MatTek Corp. fell between -100 and -14k Ohms (with only 3 
measurements out of 60 outside the acceptable range for the entire dataset).  Since most 
of the measured tissue reactance values fell within the accurate range for the ELVIS 
system, one can be confident in concluding that ELVIS accurately reported the reactance 
measurements that were inputted during these experiments. 
 Since the possible measured values of resistance and reactance both fall in the 
range of what is accurately measured by the ELVIS data acquisition system, one can 
conclude that conclusions made about impedance (which is a combination of resistance 
and reactance.  See Equation 1) may be made from the data gathered using ELVIS and 
that the data is valid. 
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Bipolar Electrode and Electrode Fixture Validation Discussion 
 
 The resistance and capacitance data gathered during the validation of the bipolar 
electrodes and electrode fixture was presented in Tables 5 and 6.  It is important that the 
bipolar electrodes and electrode fixture did not cause the measured electrical properties to 
be skewed.  If the bipolar electrode and electrode fixture did not affect the electrical 
properties measured by ELVIS, the resistance and capacitance values reported by ELVIS 
should be similar to the listed values of the resistors and capacitors used during the 
ELVIS validation. 
 From the bipolar electrode and electrode fixture validation data presented in Table 
5, ELVIS accurately measured the resistance of resistors (within a 5% margin of error 
that was reported by the manufactures) between the values of 100 to 100k Ohms (note 
that this is the same range for the ELVIS validation above).  Since the addition of using 
the bipolar electrodes and electrode fixture did not affect the range of resistance values 
that the ELVIS system accurately reported, one can conclude that the bipolar electrodes 
and electrode fixture did not significantly affect the resistance measurements. 
 From the bipolar electrode and electrode fixture validation data presented in Table 
6, ELVIS accurately measured the reactance of capacitors (within a 5% margin of error 
that was reported by the manufactures) between the values of approximately -100 and -
1.6k Ohms (note that this is the same range for the ELVIS validation above).  Since the 
addition of using the bipolar electrodes and electrode fixture did not affect the range of 
reactance values that the ELVIS system accurately reported, one can conclude that the 
bipolar electrodes and electrode fixture did not significantly affect the reactance 
measurements. 
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 Since the bipolar electrodes and electrode fixture did not affect the range of 
accurate values of resistance and reactance that is measured by the ELVIS data 
acquisition system, one can conclude that conclusions about impedance may be made 
from the data gathered using ELVIS and that the data is valid. 
 
Raw Chicken Discussion 
 
 The resistance and reactance data for the raw chicken experiments was presented 
in Tables 7 through 10.  The purpose of these measurements was to do a preliminary 
investigation of whether or not the experimental setup could distinguish different raw 
chicken tissues types based only on their electrical properties.  If the system was able to 
measure differences in the electrical properties of the different raw chicken tissue types 
(skin, meat, and fat), separate groupings of the resistance and reactance measurements 
should be visible, and there should be a statistical difference between the average 
impedance for each group. 
 By visually examining the raw chicken data presented in the boxplots of raw 
chicken and the stated mean averages in the “Data” section, one can see that the 
resistance measurements for each tissue type are grouped separately.  The average 
resistance for each tissue type is different, and there is little overlap between the first and 
third quartiles for each tissue type.  Examining the boxplots for reactance, one can see 
that the measured reactance for skin and meat are similar, but the reactance for fat is 
different for both.  When the impedance is calculated for the tissue types using Equation 
2, resistance dominates and the impedance measurements are different for each tissue 
sample.  Examining the scatterplot of raw chicken data confirms that the electrical 
properties are separately grouped.   
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 Although the raw chicken data seems to show visually that the experimental setup 
was able to find differences in the electrical properties of the three tissue types, it is 
important to make sure that any difference is statistically significant, and not due to 
random variations.  To illustrate that the differences between the tissue types are 
statistically significant, an ANOVA test was performed on the impedance values using 
Minitab.  The null hypothesis was chosen to be that there is no difference between the 
mean impedance values and the alternative hypothesis was chosen to be that there is a 
difference between at least one impedance mean. A significance value of 0.05 (meaning 
there will be a 5% chance that the conclusion is wrong) was also chosen.  Minitab 
calculated a p-value of 0.000.  Since 0.000 < 0.05, the null hypothesis is rejected and the 
alternative hypothesis is concluded to be true. 
 It makes sense that the different raw chicken tissues have different impedance 
values.  Skin, muscle (or meat), and fat are all different structurally.  The different 
structures cause differences in the ability of ions to flow through the tissues.  Also, some 
tissues may have more ions and water available to transport an electrical current. 
From this analysis, one can conclude that a statistical difference in the impedance 
values between the raw chicken tissue types was recorded by the experimental setup and 
the system was able to distinguish between tissues.  This means that it is possible to 
differentiate between tissues by examining their electrical properties. 
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Cooked Chicken Discussion 
 
 The resistance and reactance data for the cooked chicken experiments was 
presented in Tables 11 through 14.  The purpose of these measurements was to do a 
secondary investigation of whether or not the experimental setup could distinguish 
different tissues types based only on their electrical properties, and also to create a 
database of cooked tissue measurements to later compare with the raw chicken tissue data 
(see “Raw Chicken versus Cooked Chicken Discussion” section).  A secondary purpose 
for cooking the chicken tissue was to simulate tissue with lower water content and 
examine how this affects the electrical properties (this discussion will take place in the 
next section, “Raw Chicken versus Cooked Chicken Discussion”).  If the system was able 
to measure differences in the electrical properties of the different cooked chicken tissue 
types (skin, meat, and fat), separate groupings of the resistance and reactance 
measurements should be visible, and there should be a statistical difference between the 
average impedance for each group. 
 By visually examining the cooked chicken data presented in the boxplots for 
cooked chicken, one can see that the resistance measurements for each tissue type are 
grouped separately.  The mean average resistance for each tissue type is different, and 
there is no overlap between the first and third quartiles for each tissue type.  Examining 
the boxplots for reactance, one can see that the there is also a difference in the reactance 
measurements for each tissue.  When the impedance is calculated for the tissue types 
using Equation 2, the impedance measurements are different for each tissue sample.  
Examining the scatterplot of cooked chicken data confirms that the electrical properties 
are grouped separately.  It is interesting to note the different amounts of variance between 
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the tissue types.  The measurements for meat are tightly grouped and have a small 
variance, the measurements for skin have a larger grouping, and the measurements for fat 
have a very large grouping.  This is probably due to the fact that the chicken meat cooked 
the most uniformly, with an even distribution of water content throughout the tissue.  The 
skin and fat may not have cooked as uniformly, and contained areas of both high and low 
water content. 
 Although the cooked chicken data seems to show visually that the experimental 
setup was able to find differences in the electrical properties of the three tissue types, it is 
important to make sure that any difference is statistically significant, and not due to 
random variations.  To show that the difference between tissue types is statistically 
significant, an ANOVA test was performed on the impedance values using Minitab.  The 
null hypothesis was chosen to be that there is no difference between the mean impedance 
values and the alternative hypothesis was chosen to be that there is a difference between 
at least one impedance mean.  A significance value of 0.05 (meaning there will be a 5% 
chance that the conclusion is wrong) was also chosen.  Minitab calculated a p-value of 
0.000.  Since 0.000 < 0.05, the null hypothesis is rejected and the alternative hypothesis 
is concluded to be true. 
From this analysis, one can conclude that a statistical difference in the impedance 
values between the cooked chicken tissue types was recorded by the experimental setup 
and the system was able to distinguish between tissues.  This reinforces the previous 
conclusion found during the raw chicken experiments that the experimental system was 
able to distinguish the differences between tissues by examining only the electrical 
properties of the tissue. 
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Raw Chicken versus Cooked Chicken Discussion 
 
 The conclusion has been reached that the experimental setup was able to detect 
differences in the electrical properties between different tissue types for both raw and 
cooked chicken.  To even further validate the fact that the experimental setup is able to 
distinguish between tissues, the electrical property data for each tissue type will were 
compared against each other for the raw and cooked chicken groups.  If there is a 
statistical difference, one can conclude that the setup was able to detect a difference in the 
electrical properties of a tissue type based on the water content of the tissue (cooking the 
tissue was done in order to remove water content), for the same type of tissue.  This is 
important because one of the primary differences between normal and cancerous tissue is 
water content.  If a diagnosis system based on electrical properties is going to be able to 
detect the difference between normal and cancerous tissue, it will have to do so at least in 
part by detecting a difference in water content. 
 Scatterplots for the electrical properties of each tissue type (for raw vs. cooked) 
were presented above.  By visually inspecting these graphs, one can see that there seems 
to be separate groupings between raw and cooked tissue.  This suggests that cooking 
tissue causes a change in electrical properties due to a loss of water content in the tissue.   
 To show that there is a statistical difference between the raw and cooked chicken 
impedance measurements for each tissue type, 2 Sample Student’s T-tests were 
performed for each tissue type (2 Sample Student’s T-tests are the same as ANOVA tests 
when comparing data from two samples).  The null and alternative hypothesizes for each 
grouping were chosen to be that there is no difference between the impedance means and 
that there is a difference between the impedance means, respectively.  A significance 
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value of 0.05 (meaning there is only a 5% chance the conclusion is wrong) was chosen.  
Minitab calculated the following p-values: 
Table 18 – P Values 
Test P-Value 
Raw vs. Cooked Skin 0.002 
Raw vs. Cooked Meat 0.000 
Raw vs. Cooked Fat 0.000 
 
Since p-value < 0.05 for each test, each null hypothesis is rejected and each alternative 
hypothesis is concluded to be true. 
From the analysis, we can conclude there is a statistical difference of the electrical 
properties between raw and cooked for each tissue type.  Thus, we can conclude that the 
experimental setup was able to detect differences in the electrical properties of a tissue 
based on a change in water content.  This further reinforces the conclusion that the 
experimental setup is capable of detecting different tissue types by examining the 
electrical properties of the tissues.  Since these methods have worked to distinguish 
different chicken tissue types, it may be possible that they can distinguish between 
healthy and melanoma tissue. 
 
EpiDermTM and MelanomaTM Discussion 
 
 Now that it has been shown that the experimental methods can detect differences 
in tissue via measured electrical properties, what conclusions, if any, can one come to 
about the human skin analogues data?  The data gathered from the measurement of 
EpiDermTM and MelanomaTM skin analogues was presented in Tables 15 through 17.  
The purpose of these measurements was to determine if there is a statistical difference 
between the two types.  If there is, melanoma could be diagnosed in the future by 
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measuring the electrical properties of the suspected tumor and comparing the results to 
known ranges for healthy and cancerous skin. 
 By visually examining the scatterplots of resistance and reactance for EpiDermTM, 
one can see that a large amount of the data points are grouped together, which suggest 
reliable measurement.  By visually examining the scatterplot and boxplot of the 
MelanomaTM data, one can see that there is one group of data points that is tightly 
grouped, while other data points are widely scattered.  However, the data for each tissue 
type is not meant to be examined on its own, they should be compared with each other.  
When the data from EpiDermTM and MelanomaTM is put on the same scatterplot, one can 
see that the tight grouping of the MelanomaTM data lies directly over the EpiDermTM data, 
while the other grouping of MelanomaTM data is distinctly separate. 
 The question arises: why are there two separate groupings of the MelanomaTM 
data, and what can be concluded from it?  It has already been shown that the 
measurements made by the ELVIS system, bipolar electrode, and electrode fixture 
system are accurate, so it unlikely that the two groupings is due to measurement error.  
Also, the large number of data points in the second MelanomaTM group (18 out of 48 total 
data points) suggests that they are not a random occurrence, but rather an actual property 
of the MelanomaTM samples.  The main difference between the EpiDermTM and 
MelanomaTM samples is that the MelanomaTM samples have melanoma cells (see the 
“Validation and Experimental Tissues” section).  It is possible that the melanoma was not 
evenly distributed throughout the tissue samples.  It is important to remember that the 
tissue samples were rotated 45 degrees between each measurement, meaning a different 
portion of the sample was recorded for each measurement.  We can therefore confidently 
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assume that the two distinct groupings of the MelanomaTM data was caused by the 
electrodes sometimes measuring the normal tissue cells (which were the same as the 
EpiDermTM samples), while at other times, the measurements were affected by the 
melanoma cells.  Now that the reason for the separate groupings of the MelanomaTM data 
has been found, we can investigate if whether or not there is a statistical difference 
between the EpiDermTM and MelanomaTM data. 
 To show that the difference between the EpiDermTM and MelanomaTM data is 
statistically significant, an ANOVA test was performed on the impedance values using 
Minitab.  The null hypothesis was chosen to be that there is no difference between the 
mean impedance values and the alternative hypothesis was chosen to be that there is a 
difference between at least one impedance mean.  A significance value of 0.05 (meaning 
there will be a 5% chance that the conclusion is wrong) was also chosen.  Minitab 
calculated a p-value of 0.001.  Since 0.001 < 0.05, the null hypothesis is rejected and the 
alternative hypothesis is concluded to be true.   
 Using Minitab, it has been shown that there is a statistical difference between the 
electrical properties of EpiDermTM and MelanomaTM data measured by the experimental 
setup. 
 It is interesting to note that the resistance of the MelanomaTM samples where 
cancer was detected the resistance was higher than the non-cancerous EpiDermTM 
samples.  This trend conflicts with the previous research done by Rigaud, B, et al (see the 
“Electrical Properties of Skin” section).  A possible explanation for this discrepancy is 
that Rigaud performed his measurements and analysis on in vivo samples, whereas the 
data collected for this thesis used in vitro samples. 
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Final Conclusions 
 
 Using the gathered data and statistical analysis, the ELVIS data acquisition 
system, AgCl bipolar electrodes, and electrode fixture have been validated and can be 
used to reliably and accurately measure a material's electrical properties.  Once the 
validity of the experimental system was established, it was shown that the system could 
detect significant differences in the electrical properties of different chicken tissue types.  
It was shown that the system could also distinguish between the same tissue types when 
the water content of one sample had been lowered.  Finally, it was shown that the system 
was able to distinguish differences between healthy and cancerous human skin tissue 
analogues (when enough data points are taken so that the melanoma cells can be 
measured).  This means that it may be possible to diagnose melanoma by examination of 
the electrical properties of the suspected tissue. 
 Now that it has been established that this type of system can distinguish between 
normal and melanoma human skin analogues, the next step would be to test this system 
on actual human skin samples, in vitro and then in vivo.  Although the skin analogue data 
provided clear differences between healthy and cancerous tissue, the differences for 
actual human tissue may not be as great.  Human skin is more complex (the dermis 
contains nerve, blood vessels, and hair follicles), which may make the differences 
between healthy and cancerous skin not as significant.  However, this does not mean that 
this method cannot be used to diagnose melanoma in vivo.  As long as a database with a 
large amount of data points is constructed, and enough data points of the suspected tumor 
are taken, a statistical conclusion and diagnosis could still be made.    
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The main goal of this thesis has been achieved; measurable differences in the 
electrical properties of healthy and cancerous tissue have been recorded.  A larger and 
more complete database of healthy and cancerous tissue electrical properties can now be 
established, and ranges for each tissue can be defined.  Then, when a new measurement is 
taken of a suspected tumor, the new data point can be compared to known values for 
healthy and cancerous skin, and a diagnosis can be made.
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Next Steps: Diagnose and Treat Melanoma  
 
 The following sections are meant to be suggestions for future research and 
experimentation to build on the work of this thesis.  The author believes that the research 
and data gathered for this thesis can be expanded and further investigated in the areas of 
in-vivo cancer diagnosis and treatment.  Since the diagnosis method of melanoma has 
already been thoroughly examined, the following sections will focus on a novel 
melanoma treatment method using radiofrequency tissue ablation.  How such a device 
might look and function will be discussed along with previous uses of radiofrequency 
tissue ablation to treat cancer. The actual building of such a device is out of the scope for 
this thesis, and will be reserved for a student at a later time.  The purpose of the following 
sections is to facilitate the next steps in the project.  Further research, testing, and analysis 
will need to be performed to continue this work. 
 
Tissue Ablation 
 
Introduction to Tissue Ablation 
 
 Since the one of goals of this thesis was to also investigate a method of skin 
cancer treatment, radiofrequency tissue ablation is also investigated.  Radiofrequency 
tissue ablation uses an alternating current delivered to the target tissue to cause localized 
heating of the tissue, which destroys a small volume of tissue without affecting other 
surrounding structures beyond the treatment site [8].  Radiofrequency tissue ablation has 
already been approved by the Food and Drug Admisnistration to treat some diseases such 
as: liver cancer, kidney cancer, and lung tumors [1].  It is a preferred method of treatment 
when a patient has co-morbidities or is not healthy enough for a more invasive treatment 
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[28].  The following sections will provide information on: how radiofrequency tissue 
ablation works, how it treats cancer, and also previous studies where radiofrequency 
tissue ablation was used to treat liver and breast cancer.  No previous uses of 
radiofrequency tissue ablation to treat skin cancer were found in the literature. 
 
What is Tissue Ablation? 
 
 Ablation is a term that is used to describe a procedure performed on the body to 
destroy diseased or damaged structures [8].  Ablation can use heat, cold, or chemicals to 
destroy tissue.  This thesis will focus on radiofrequency tissue ablation, which uses the 
direct application of electrical energy to a specific area in an attempt to cause thermal 
injury and necrosis of the tissue [29].   
 
How Radiofrequency Tissue Ablation Works 
 
  Radiofrequency tissue ablation creates heat in the targeted tissue by applying a 
current to the tissue using electrodes.  A generator creates a sinusoidal alternating 
electrical current.  The signal is generally in the 375 kHz to 500 kHz range, which 
corresponds to the radiofrequency area of the electromagnetic spectrum.  Most devices 
that are currently used are monopolar.  This means that a single electrode delivers the 
alternating current signal to the tissue, and the signal returns to the generator through a 
large grounding pad attached to the patient [29].  The current must travel through the 
patient in order to complete the circuit.  For devices that are bipolar, the current is 
delivered to the tissue using an electrode and returns to the generator via a nearby 
electrode. 
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 The treatment thermal heat is generated by friction.  As the alternating current 
oscillates back and forth between the electrode and grounding pad or other electrode, 
charged ions and water molecules in the tissue in the current path vibrate back and forth 
trying to follow the oscillation of the current.   This ionic agitation leads to frictional 
heating of the tissue [21].  Thermal injury of the tissue starts at 41 degrees Celsius, and 
necrosis of cells occurs at 46 degrees Celsius [19].  Necrosis occurs because of the 
denaturing of proteins vital to cell life and the loss of intracellular fluid [21].   
 
Radiofrequency Tissue Ablation and Cancer 
 
 Radiofrequency tissue ablation is considered a reliable treatment method to 
destroy some types of tumors because it can be used to cause cell necrosis in a small, 
targeted area without affecting structures beyond the treatment site [1].  Radiofrequency 
tissue ablation is considered safer than other ablation and treatment methods because 
excess energy is absorbed in nearby tissues as simple heat [8].  Radiofrequency tissue 
ablation treats cancer by killing the cancerous cells, which stops the ability of the cells to 
replicate and spread.  Radiofrequency tissue ablation also has the ability to kill healthy 
cells.  To stop the treatment from damaging healthy tissue, the treatment must be 
monitored by the doctor or generator supplying the electrical current.   
 As the current is applied to a tumor, changes occur in the tissue.  A decrease in the 
ability of the soft tissue to conduct current occurs (see the previous “Practical 
Observations” section).  This leads to an increase in resistance seen by the generator.  
This allows for the progress of the treatment to be monitored by monitoring the increase 
in impedance [21]. 
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 The two types of cancer that are often treated with radiofrequency tissue ablation 
are liver and breast cancer.  The following section will provide information on studies 
conducted using radiofrequency tissue ablation on these cancers.  Again, it is important to 
note that no previous investigations into using radiofrequency tissue ablation for the 
treatment of skin cancer were found. 
 
Liver Cancer 
 
 In a 1998 study entitled “Ablation of Liver Tumors Using Percutaneous RF 
Therapy,” Goldberg, Gazelle, et al. treated 29 patients who had a total of 44 hepatic 
metastases.  The purpose of the study was to determine what, if any, effects internally 
cooled electrodes had on the volume of ablated tissue. 
 The researchers used a 500 kHz monopolar generator which not only provided 
output energy but also measured output to the tissue, tissue impedance, and electrode tip 
temperature.  The current supplied by the generator was delivered to the liver metastases 
with 18 gauge needles that were insulated except for the last 1-3 inches.  The researchers' 
experimental group of electrodes was internally cooled, where cooled perfusate was 
circulated through the center of the electrode.  The purpose of internally cooled 
electrodes is to lower the temperature of the tissue at the tip of the electrode, in an 
attempt to prevent burning of the tissue and to increase the volume of the ablated tissue.  
The tip of the electrode was placed directly in the center of the tumors under the guidance 
of ultrasound or CT scan.   
 After performing the treatment, the volume of ablated tissue was measured with a 
CT scan.  The volume of ablated tissue with traditional electrodes was limited to an 
average of 1.6 cm diameter (see Figure 26 [30]).  To create a larger volume with standard 
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electrodes, the power to the tissue must be increased which results in tissue vaporization 
and charring.  Internally cooled electrodes however can ablate an average volume of 2.4 
cm diameter.  This is because since the electrode tip is cooled, more energy can be 
deposited into the tissue [31].  The researchers also noticed that the volume of ablated 
tissue is affected by the presence of large blood vessels in the vicinity of the treatment 
site.  The flow of blood acts as a heat sink and keeps the tissue from reaching the required 
temperature for necrosis. 
  
 Overall, the researchers were able to create volumes of necrosis of 1.5 to 4.5 cm 
in diameter.  Of the 29 patients treated, 94% were alive after 12 months.  50% of the 
patients were still disease free after 12 months [30]. 
 Other research by Solbiati, et al., also showed that radiofrequency tissue ablation 
could be used to effectively treat liver cancer.  Solbiati’s group used ultrasound imaging 
techniques to guide the ablation electrode to the tumor [32]. 
Figure 26 – Radiofrequency Ablation of the Liver 
 
An example of liver tissue after treatment with 
radiofrequency tissue ablation 
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Breast Cancer 
 
 In the 1999 study entitled, “Radiofrequency Ablation of Breast Cancer,” Jeffrey, 
Birdwell, et al, treated 5 women with breast cancer with radiofrequency energy right 
before the resection of their tumors.  They were attempting to determine if 
radiofrequency tissue ablation is an acceptable treatment method for breast cancer. 
 The patients were treated with a 15 gauge multiple needle electrode for 30 
minutes using a monopolar generator.  The generator continuously monitored the power 
applied to the tissue and the impedance seen by the electrodes.  As the treatment 
progressed, the impedance increased by a factor of ten and the power declined.  The 
researchers used this phenomenon to monitor the treatment.  After the treatment, the 
breasts were resected and the tumor was examined with an enzyme histochemical 
analysis.  The researchers noticed that the ablated tissue appeared the same to the naked 
eye as the non-treated tissue.  Under the histochemical analysis however, there was a 
clear and defined line separating treated and non-treated tissue. 
 The researchers found evidence of cell death in all patients.  The enzyme 
histochemical analysis showed that the radiofrequency tissue ablation caused a volume of 
necrosis with a diameter of 0.8 cm to 1.8 cm.  From these results, the researchers were 
able to conclude that radiofrequency tissue ablation of breast cancer results in cell death 
[19]. 
 Other research by Livraghi, et al., has also shown that radiofrequency tissue 
ablation can be an effective treatment method for breast cancer [33]. 
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Skin Cancer and Radiofrequency Tissue Ablation 
 
 Currently, there are no published papers on the use of radiofrequency tissue 
ablation to treat skin cancer.  The author believes that this lack of previous treatment or 
experimentation allows for a good opportunity to investigate the ability of radiofrequency 
tissue ablation to treat skin cancer.  Also, since radiofrequency tissue ablation has been 
show to be effective for treating other type of cancer, there is reason to believe that it 
would also be affective for treating skin cancer. 
 
Bipolar versus Monopolar Electrodes 
 
 Tissue ablations that are currently used employ monopolar electrode systems.  In a 
monopolar electrode system, the alternating current from the generator is delivered to the 
tissue by a single electrode (although this single electrode may have multiple leads).  This 
electrode is inserted through the skin and directly into the tissue and placed in the center 
of the area that is to be treated.  A grounding pad is placed on the thigh or back of the 
patient.  The therapeutic current disperses through the body before traveling to the 
grounding pad to complete the electrical circuit.  Since the current is delivered by one 
electrode and spreads out from that electrode toward the grounding pad, the volume of 
ablated tissue spreads out in a spherical fashion from the tip of the electrode.  The longer 
the current is applied, and the stronger the current, the larger the treatment volume.  
Because the treatment volume of ablated tissue spreads in a spherical fashion and evenly 
from the electrode, it is difficult to control what tissue is ablated besides by controlling 
the size of the sphere. 
 Another type of tissue ablation method uses bipolar electrodes.  In a bipolar 
electrode system, the alternating current from the generator is delivered to the tissue by 
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two closely spaced electrodes.  The current alternates back and forth between the two 
electrodes, instead of returning to grounding pad.  Because the treatment current only 
travels between two electrodes, only the tissue that is between the two electrodes is 
ablated.  This allows for much greater control over the ablated tissue.  The volume of 
ablated tissue depends on the amount of time the current is applied, the strength of the 
current, and the configuration of the electrodes.  Having this greater controls allows for 
some structures to be treated, while other structures nearby are not treated. 
 The author believes that a bipolar electrode system should be used when treating 
skin cancer with radiofrequency tissue ablation.  Since melanoma lesions are relatively 
small compared to other cancers (<4 mm diameter), bipolar electrodes would allow 
greater control to ensure that only cancerous tissue is ablated and healthy tissue is not.  
The following sections will go into greater depth on how this can be achieved. 
 
How Tissue Ablation will be used to treat Skin Cancer 
 
 The following sections will outline how the author believes skin cancer can be 
diagnosed and treated using a bipolar electrode system.  These sections will include 
information on: the difference between healthy and cancerous tissue and how this may 
allow for a new method of cancer diagnosis, the electrode setup for such a device, and the 
generator which will provide the treatment current.  Please note that the following 
sections are the opinions of the author, and will need to be validated by future 
experimentation and research. 
 
 
 
109 
 
Difference between Healthy and Cancerous Tissue 
 
 The differences between healthy tissue and cancerous tissue will play a large role 
in the treatment of skin cancer using tissue ablation.  It has been established by this thesis 
(see the “Conclusions” section) that a difference between the impedance of normal tissue 
and tissue containing melanoma cells is measurable.  This fact will not only be important 
in the diagnosis of a tumor, but it can also be used to facilitate the treatment of the tumor 
using tissue ablation.   
 The data gathered for this thesis established the fact that melanoma tissue has 
higher impedance than normal tissue.  This fact can be used to diagnose and selectively 
treat only tissue that matches the criteria of melanoma tissue.  To do this, a “scan” of the 
electrical impedance of the suspected tumor and the surrounded area can be made using a 
device and electrode setup that is described below.  A model of the scanned tissue can be 
made in a computer and the area of cancer that needs treatment can be identified and 
highlighted.  Once the specific area of skin that needs treatment has been identified, the 
tissue ablation treatment can progress.  This can be done by selectively targeting the 
highlighted cancerous areas.  By only treating the cancerous skin, the surrounding healthy 
tissue can be left alone.  This will decrease scarring and healing times by minimizing the 
treatment area. 
 
Electrodes 
 
 The electrodes of the ablation device should be configured in a way that will 
allow for the most control over the treatment area.  Using a matrix of bipolar electrodes 
will allow the system to analyze skin electrical properties and to map healthy and 
cancerous tissue, and then apply the treatment electrical current only to the tissue that has 
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been determined to be cancerous.  A matrix of electrodes will allow the system to analyze 
and treat a two dimensional area of tissue, instead of just a one dimensional area between 
two point electrodes.  Measurements of the skin's electrical properties will be measured 
between each electrode, creating a “map” of the scanned tissue.  The data will be 
processed by a computer in the generator to determine the area of cancerous tissue.  Once 
this area has been determined, the generator can supply the electrical current to the 
electrodes that touch the area of cancerous tissue.  This will cause the cancerous tissue to 
be ablated, while leaving tissue that has been determined to be healthy untreated. 
 The electrodes will be bipolar.  This means that the electrical current for both 
diagnosis and treatment will only travel from one electrode to another on the device.  
There will not be a grounding pad.  Bipolar electrodes will allow the treatment area to be 
much more controlled because the treatment will only be applied between electrodes, 
instead of spreading out from one electrode toward the grounding pad. 
 The density of electrodes used in the matrix will affect the resolution of the 
system to both diagnose melanoma and the area that can be treated with radiofrequency 
tissue ablation.  In other words, the more electrodes per unit of area, the more accurate 
the system will be able to build a model of the cancerous tissue and the better it will be at 
applying a treatment current to only the identified tissue.  The resolution should be small 
enough to detect the smallest structures of skin cancer that can be detected through other 
diagnosis techniques.  The optimum electrode density will have to be investigated in later 
experimentations. 
 The electrodes will be made of an AgCl compound.  The reasons to use this 
material are the same for why AgCl was used to gather the data earlier in this thesis.  
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AgCl does not create a charge density around the electrode.  A charge density occurs 
when ions in the sample are attracted to the electrode due to the alternating current.  
These ions accumulate and interfere with the measurements at the electrode-tissue 
interface. AgCl electrodes also do not exhibit polarization when a voltage is applied. 
 
Generator 
 
 To create the electrical signal that is needed to ablate the cancerous tissue, an 
electrical generator is needed.  The generator creates the electrical signal with the 
appropriate voltage and frequency.  The signal travels from the generator to the 
electrodes via conductive wires.   
 Certain signal properties are often used for the ablation of human tissue.  A 
generator used for tissue ablation will have an output power of approximately 100 Watts 
and a frequency of 490 kHz.  This frequency corresponds to the radiofrequency section of 
the electromagnetic spectrum.   These power and frequency values correspond to 
previous uses of Radiofrequency tissue ablation to treat other types of cancers. 
 Generators also have the ability to monitor the progress of the treatment while the 
treatment signal is being applied.  The generators accomplish this by monitoring the 
impedance of the tissue at the treatment site.  As the tissue is treated, the impedance 
measured by the generator changes.  When the impedance reaches a determined level that 
corresponds to successful tissue ablation, the generator will automatically stop the 
treatment.  This capability allows treatment to be completed without the possibility of 
over treating the tissue, which could lead to burning. 
 The generator can also contain the necessary computer hardware and software to 
build the tissue model from the diagnosis data.  This model is used to identify the 
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cancerous tissue that needs treatment.  Once this tissue has been identified, the computer 
will program the generator to only apply the treatment current through the electrodes that 
are over the melanoma. 
 
Summary of Future Work 
 
The fundamentals of radiofrequency tissue ablation, the previous uses of this 
treatment method to treat cancer, and the possible look of a system that could be used to 
treat melanoma have been outlined.  A radiofrequency tissue ablation system could be 
used alongside a diagnosis method that distinguishes between normal and cancerous skin 
by examining the electrical properties of the tissue to treat melanoma.  Such a system 
would have the benefits of being less invasive to the patient and make more accurate 
diagnoses over current diagnosis and treatment methods. 
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Appendix 
 
Drawing of electrode fixture, labeled as “Part 1” in “Electrode Fixture” section. 
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Drawing of electrode fixture, labeled as “Part 2” in “Electrode Fixture” section. 
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Assembly drawing of electrode fixture. 
